| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.865 | 0.005 | 0.865 | Analgesic | 0.835 0.005 DBMET01807 0.635 0.021 DB03610 | ||
| 0.756 | 0.003 | 0.756 | 5 Hydroxytryptamine uptake inhibitor | 0.647 0.004 DBMET01807 0.287 0.007 DBMET01565 | ||
| 0.621 | 0.005 | 0.621 | Calcium channel L-type activator | 0.519 0.021 DBMET01807 0.599 0.006 DBMET01565 0.558 0.012 DB03610 | ||
| 0.625 | 0.012 | 0.747 | 5 Hydroxytryptamine release stimulant | 0.618 0.013 DBMET01807 0.619 0.013 DBMET01565 0.747 0.005 DB03610 | DB03610 | |
| 0.596 | 0.003 | 0.596 | Adrenaline uptake inhibitor | 0.4 0.004 DBMET01807 0.258 0.005 DBMET01565 | ||
| 0.574 | 0.007 | 0.574 | Psychostimulant | 0.484 0.012 DBMET01807 0.472 0.014 DBMET01565 0.18 0.093 DB03610 | ||
| 0.492 | 0.013 | 0.535 | Anticonvulsant | 0.535 0.01 DBMET01807 0.226 0.067 DBMET01565 0.153 0.125 DB03610 | DBMET01807 | |
| 0.504 | 0.036 | 0.528 | Antiobesity | 0.528 0.032 DBMET01807 0.313 0.108 DB03610 | DBMET01807 | |
| 0.475 | 0.019 | 0.477 | Vasodilator, coronary | 0.411 0.032 DBMET01807 0.477 0.019 DBMET01565 0.286 0.1 DB03610 | DBMET01565 | |
| 0.429 | 0.016 | 0.441 | Calcium channel activator | 0.382 0.032 DBMET01807 0.371 0.037 DBMET01565 0.441 0.013 DB03610 | DB03610 | |
| 0.397 | 0.002 | 0.397 | Toll-Like receptor 3 antagonist | 0.341 0.003 DBMET01807 0.257 0.004 DBMET01565 | ||
| 0.445 | 0.065 | 0.51 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.355 0.145 DBMET01807 0.502 0.033 DBMET01565 0.51 0.029 DB03610 | DB03610 | |
| 0.401 | 0.028 | 0.401 | Antiamyloidogenic | 0.39 0.03 DBMET01807 0.197 0.101 DBMET01565 0.332 0.043 DB03610 | ||
| 0.347 | 0.01 | 0.347 | 5 Hydroxytryptamine 1E antagonist | 0.301 0.029 DBMET01807 0.303 0.028 DBMET01565 0.226 0.102 DB03610 | ||
| 0.333 | 0.01 | 0.333 | Antipruritic | 0.331 0.01 DBMET01807 0.136 0.112 DBMET01565 0.23 0.032 DB03610 | ||
| 0.407 | 0.087 | 0.502 | Cyclophilin D inhibitor | 0.472 0.059 DBMET01807 0.502 0.049 DB03610 | DB03610 | |
| 0.372 | 0.07 | 0.454 | Transcription factor NF kappa B inhibitor | 0.379 0.068 DBMET01807 0.347 0.078 DBMET01565 0.454 0.052 DB03610 | DB03610 | |
| 0.319 | 0.019 | 0.334 | Peptidyltransferase inhibitor | 0.334 0.015 DBMET01807 0.323 0.018 DBMET01565 | DBMET01807 | |
| 0.29 | 0.004 | 0.291 | Inducible nitric-oxide synthase inhibitor | 0.291 0.004 DBMET01807 0.159 0.014 DBMET01565 0.095 0.042 DB03610 | DBMET01807 | |
| 0.294 | 0.01 | 0.294 | Calcium channel blocker | 0.225 0.022 DBMET01807 0.134 0.073 DBMET01565 0.129 0.077 DB03610 | ||
| 0.295 | 0.017 | 0.295 | 5 Hydroxytryptamine 2 antagonist | 0.173 0.037 DBMET01807 0.163 0.04 DBMET01565 | ||
| 0.321 | 0.043 | 0.321 | Potassium channel (Voltage-sensitive) blocker | 0.254 0.065 DBMET01807 | ||
| 0.392 | 0.116 | 0.757 | Caspase 9 stimulant | 0.438 0.089 DBMET01807 0.388 0.118 DBMET01565 0.757 0.017 DB03610 | DB03610 | |
| 0.28 | 0.011 | 0.28 | Alpha 2b adrenoreceptor antagonist | 0.157 0.036 DBMET01807 0.213 0.021 DBMET01565 | ||
| 0.308 | 0.044 | 0.308 | Potassium channel blocker | 0.23 0.076 DBMET01807 | ||
| 0.258 | 0.005 | 0.258 | Nitric-oxide synthase inhibitor | 0.255 0.005 DBMET01807 0.236 0.005 DBMET01565 0.088 0.081 DB03610 | ||
| 0.3 | 0.049 | 0.3 | HERG channel blocker | 0.254 0.064 DBMET01807 | ||
| 0.242 | 0.004 | 0.242 | Glycine transporter inhibitor | 0.21 0.004 DBMET01807 0.056 0.027 DB03610 | ||
| 0.224 | 0.004 | 0.241 | Glycine transporter 1 inhibitor | 0.241 0.004 DBMET01807 | DBMET01807 | |
| 0.217 | 0.007 | 0.217 | Sphingomyelinase inhibitor | 0.161 0.02 DBMET01807 0.206 0.009 DBMET01565 0.142 0.028 DB03610 | ||
| 0.226 | 0.017 | 0.226 | 5 Hydroxytryptamine 2A antagonist | 0.128 0.035 DBMET01807 0.112 0.041 DBMET01565 | ||
| 0.213 | 0.005 | 0.213 | TRPA1 antagonist | 0.137 0.011 DBMET01807 0.056 0.048 DBMET01565 0.194 0.005 DB03610 | ||
| 0.296 | 0.093 | 0.582 | Cholesterol antagonist | 0.298 0.093 DBMET01807 0.322 0.078 DBMET01565 0.582 0.021 DB03610 | DB03610 | |
| 0.206 | 0.006 | 0.206 | Dopamine uptake inhibitor | 0.119 0.014 DBMET01807 0.108 0.017 DBMET01565 | ||
| 0.209 | 0.011 | 0.209 | Nav1.5 sodium channel blocker | 0.202 0.012 DBMET01807 0.173 0.018 DB03610 | ||
| 0.217 | 0.021 | 0.217 | Antiadrenergic | 0.145 0.037 DBMET01807 | ||
| 0.2 | 0.005 | 0.229 | Glutamate release inhibitor | 0.216 0.004 DBMET01807 0.115 0.026 DBMET01565 0.229 0.004 DB03610 | DB03610 | |
| 0.211 | 0.016 | 0.211 | 5 Hydroxytryptamine 2C antagonist | 0.141 0.029 DBMET01807 0.128 0.033 DBMET01565 | ||
| 0.216 | 0.024 | 0.216 | Sodium channel (voltage-gated) blocker | 0.21 0.026 DBMET01807 0.183 0.036 DB03610 | ||
| 0.212 | 0.021 | 0.212 | Adrenaline antagonist | 0.142 0.037 DBMET01807 | ||
| 0.204 | 0.017 | 0.204 | Alpha 2c adrenoreceptor antagonist | 0.125 0.046 DBMET01807 0.147 0.033 DBMET01565 | ||
| 0.231 | 0.046 | 0.271 | Insulin sensitizer | 0.271 0.024 DBMET01807 0.191 0.082 DBMET01565 0.266 0.026 DB03610 | DBMET01807 | |
| 0.211 | 0.029 | 0.277 | Anesthetic local | 0.121 0.067 DBMET01807 0.277 0.015 DBMET01565 | DBMET01565 | |
| 0.219 | 0.037 | 0.288 | 5 Hydroxytryptamine 3E antagonist | 0.204 0.056 DBMET01807 0.288 0.006 DBMET01565 0.21 0.047 DB03610 | DBMET01565 | |
| 0.196 | 0.015 | 0.305 | NMDA receptor antagonist | 0.305 0.006 DBMET01807 0.095 0.05 DBMET01565 0.147 0.025 DB03610 | DBMET01807 | |
| 0.186 | 0.006 | 0.259 | Glycine transporter 2 inhibitor | 0.259 0.004 DBMET01807 0.047 0.032 DBMET01565 0.121 0.01 DB03610 | DBMET01807 | |
| 0.248 | 0.068 | 0.401 | Hypolipemic | 0.257 0.064 DBMET01807 0.401 0.025 DB03610 | DB03610 | |
| 0.203 | 0.023 | 0.215 | Nav1.3 sodium channel blocker | 0.127 0.067 DBMET01807 0.215 0.02 DBMET01565 0.156 0.044 DB03610 | DBMET01565 | |
| 0.187 | 0.008 | 0.187 | Adrenaline agonist | 0.125 0.023 DBMET01807 0.125 0.023 DBMET01565 0.104 0.034 DB03610 | ||
| 0.195 | 0.017 | 0.195 | 5 Hydroxytryptamine 1 antagonist | 0.107 0.035 DBMET01807 0.111 0.033 DBMET01565 | ||
| 0.19 | 0.022 | 0.19 | Antihistaminic | 0.103 0.052 DBMET01807 0.12 0.043 DBMET01565 | ||
| 0.222 | 0.057 | 0.498 | Neurotrophic factor enhancer | 0.219 0.06 DBMET01807 0.282 0.023 DBMET01565 0.498 0.004 DB03610 | DB03610 | |
| 0.187 | 0.023 | 0.213 | Interleukin 1b antagonist | 0.213 0.017 DBMET01807 | DBMET01807 | |
| 0.186 | 0.025 | 0.227 | Nav1.6 sodium channel blocker | 0.176 0.031 DBMET01807 0.189 0.023 DBMET01565 0.227 0.013 DB03610 | DB03610 | |
| 0.167 | 0.007 | 0.167 | Glutamate (mGluR7) agonist | 0.124 0.027 DBMET01807 0.162 0.008 DBMET01565 0.111 0.041 DB03610 | ||
| 0.195 | 0.036 | 0.235 | Nav1.2 sodium channel blocker | 0.176 0.044 DBMET01807 0.235 0.024 DBMET01565 0.184 0.04 DB03610 | DBMET01565 | |
| 0.2 | 0.042 | 0.209 | Acetylcholine M1 receptor antagonist | 0.2 0.042 DBMET01807 0.209 0.038 DBMET01565 0.117 0.114 DB03610 | DBMET01565 | |
| 0.18 | 0.022 | 0.18 | Histamine antagonist | 0.093 0.052 DBMET01807 0.111 0.042 DBMET01565 | ||
| 0.175 | 0.017 | 0.175 | 5 Hydroxytryptamine 1A antagonist | 0.112 0.028 DBMET01807 0.087 0.037 DBMET01565 | ||
| 0.191 | 0.036 | 0.191 | Sodium channel blocker | 0.178 0.041 DBMET01807 0.168 0.046 DB03610 | ||
| 0.165 | 0.012 | 0.32 | Protein kinase B gamma inhibitor | 0.32 0.004 DBMET01807 | DBMET01807 | |
| 0.187 | 0.037 | 0.187 | 5 Hydroxytryptamine antagonist | 0.112 0.07 DBMET01807 0.137 0.055 DBMET01565 | ||
| 0.157 | 0.009 | 0.157 | Calcium channel L-type blocker | 0.112 0.019 DBMET01807 0.085 0.034 DBMET01565 0.087 0.033 DB03610 | ||
| 0.221 | 0.074 | 0.432 | Interleukin antagonist | 0.432 0.026 DBMET01807 0.272 0.054 DB03610 | DBMET01807 | |
| 0.173 | 0.032 | 0.203 | Adenylate cyclase stimulant | 0.17 0.036 DBMET01807 0.203 0.012 DBMET01565 0.186 0.021 DB03610 | DBMET01565 | |
| 0.172 | 0.033 | 0.172 | 5 Hydroxytryptamine 2B antagonist | 0.134 0.049 DBMET01807 0.16 0.037 DBMET01565 | ||
| 0.139 | 0.007 | 0.139 | Beta adrenoreceptor antagonist | 0.105 0.014 DBMET01807 0.073 0.034 DBMET01565 0.076 0.031 DB03610 | ||
| 0.146 | 0.017 | 0.146 | Alpha adrenoreceptor agonist | 0.085 0.035 DBMET01807 0.089 0.033 DBMET01565 | ||
| 0.131 | 0.008 | 0.131 | Dopamine transporter inhibitor | 0.088 0.015 DBMET01807 0.088 0.015 DBMET01565 | ||
| 0.161 | 0.038 | 0.23 | Adenylate cyclase inhibitor | 0.23 0.021 DBMET01807 0.148 0.046 DBMET01565 0.23 0.021 DB03610 | DB03610 | |
| 0.143 | 0.024 | 0.143 | Alpha 2a adrenoreceptor antagonist | 0.081 0.048 DBMET01807 0.086 0.044 DBMET01565 | ||
| 0.138 | 0.019 | 0.138 | 5 Hydroxytryptamine 1F antagonist | 0.072 0.048 DBMET01807 0.102 0.03 DBMET01565 | ||
| 0.15 | 0.033 | 0.15 | Calcium channel (voltage-sensitive) blocker | 0.11 0.07 DBMET01807 0.108 0.073 DB03610 | ||
| 0.193 | 0.077 | 0.227 | I kappa B kinase epsilon inhibitor | 0.14 0.131 DBMET01807 0.169 0.1 DBMET01565 0.227 0.051 DB03610 | DB03610 | |
| 0.145 | 0.029 | 0.145 | Alpha 2 adrenoreceptor antagonist | 0.084 0.062 DBMET01807 0.093 0.053 DBMET01565 | ||
| 0.123 | 0.007 | 0.123 | Beta 1 adrenoreceptor antagonist | 0.083 0.016 DBMET01807 0.067 0.029 DBMET01565 0.069 0.027 DB03610 | ||
| 0.215 | 0.1 | 0.31 | Hypoglycemic | 0.31 0.05 DBMET01807 0.266 0.067 DB03610 | DBMET01807 | |
| 0.137 | 0.025 | 0.137 | Alpha 1b adrenoreceptor antagonist | 0.064 0.058 DBMET01807 0.092 0.039 DBMET01565 | ||
| 0.217 | 0.107 | 0.54 | Spasmolytic | 0.54 0.019 DBMET01565 0.182 0.135 DB03610 | DBMET01565 | |
| 0.205 | 0.101 | 0.31 | Vasodilator | 0.164 0.139 DBMET01807 0.31 0.045 DBMET01565 | DBMET01565 | |
| 0.143 | 0.039 | 0.143 | Alpha adrenoreceptor antagonist | 0.077 0.074 DBMET01565 | ||
| 0.109 | 0.008 | 0.131 | Factor IXa inhibitor | 0.131 0.005 DBMET01807 | DBMET01807 | |
| 0.147 | 0.049 | 0.209 | Ca2+-transporting ATPase inhibitor | 0.159 0.026 DBMET01807 0.151 0.041 DBMET01565 0.209 0.003 DB03610 | DB03610 | |
| 0.125 | 0.028 | 0.125 | Polo-like kinase-1 inhibitor | 0.118 0.031 DBMET01807 0.088 0.066 DB03610 | ||
| 0.104 | 0.007 | 0.104 | Beta 2 adrenoreceptor antagonist | 0.075 0.014 DBMET01807 0.053 0.033 DBMET01565 0.064 0.021 DB03610 | ||
| 0.153 | 0.061 | 0.207 | Toll-Like receptor 9 antagonist | 0.207 0.032 DBMET01565 | DBMET01565 | |
| 0.106 | 0.016 | 0.106 | Acetylcholine M5 receptor antagonist | 0.068 0.032 DBMET01807 0.084 0.022 DBMET01565 | ||
| 0.166 | 0.076 | 0.261 | ATPase inhibitor | 0.176 0.063 DBMET01565 0.261 0.011 DB03610 | DB03610 | |
| 0.228 | 0.146 | 0.414 | Vasodilator, peripheral | 0.414 0.051 DBMET01565 0.305 0.094 DB03610 | DBMET01565 | |
| 0.275 | 0.195 | 0.588 | 5 Hydroxytryptamine release inhibitor | 0.388 0.086 DBMET01807 0.42 0.066 DBMET01565 0.588 0.013 DB03610 | DB03610 | |
| 0.093 | 0.013 | 0.095 | Potassium channel (Tandem pore domain) blocker | 0.095 0.012 DBMET01807 0.072 0.058 DBMET01565 0.088 0.019 DB03610 | DBMET01807 | |
| 0.092 | 0.014 | 0.145 | Exportin-1 inhibitor | 0.127 0.004 DBMET01807 0.145 0.004 DB03610 | DB03610 | |
| 0.21 | 0.133 | 0.438 | 5 Hydroxytryptamine uptake stimulant | 0.275 0.06 DBMET01807 0.438 0.009 DBMET01565 0.419 0.011 DB03610 | DBMET01565 | |
| 0.101 | 0.024 | 0.171 | Estrogen-related receptor beta agonist | 0.091 0.04 DBMET01807 0.114 0.013 DBMET01565 0.171 0.003 DB03610 | DB03610 | |
| 0.094 | 0.018 | 0.094 | Alpha 1 adrenoreceptor agonist | 0.057 0.04 DBMET01807 0.067 0.029 DBMET01565 | ||
| 0.14 | 0.065 | 0.202 | Interleukin 1 antagonist | 0.202 0.032 DBMET01807 | DBMET01807 | |
| 0.099 | 0.025 | 0.156 | Sphingosine 1-phosphate receptor 4 agonist | 0.093 0.029 DBMET01807 0.067 0.047 DBMET01565 0.156 0.007 DB03610 | DB03610 | |
| 0.099 | 0.026 | 0.099 | Epoxide hydrolase inhibitor | 0.068 0.056 DBMET01807 0.086 0.036 DB03610 | ||
| 0.112 | 0.039 | 0.112 | Alpha 1 adrenoreceptor antagonist | |||
| 0.144 | 0.071 | 0.221 | Cell wall synthesis inhibitor | 0.172 0.045 DBMET01807 0.116 0.105 DBMET01565 0.221 0.023 DB03610 | DB03610 | |
| 0.135 | 0.063 | 0.2 | Sphingosine 1-phosphate receptor 2 antagonist | 0.132 0.07 DBMET01807 0.163 0.027 DBMET01565 0.2 0.008 DB03610 | DB03610 | |
| 0.081 | 0.01 | 0.138 | Neurokinin 1 antagonist | 0.086 0.009 DBMET01807 0.138 0.005 DB03610 | DB03610 | |
| 0.076 | 0.005 | 0.076 | Glucagon receptor antagonist | 0.076 0.005 DBMET01807 0.065 0.007 DB03610 | ||
| 0.089 | 0.018 | 0.089 | Beta 3 adrenoreceptor antagonist | 0.087 0.019 DBMET01565 0.086 0.02 DB03610 | ||
| 0.11 | 0.042 | 0.158 | Lanosterol 14 alpha demethylase inhibitor | 0.146 0.013 DBMET01807 0.158 0.009 DB03610 | DB03610 | |
| 0.083 | 0.016 | 0.083 | Histamine H3 receptor antagonist | 0.046 0.029 DBMET01807 0.045 0.03 DBMET01565 | ||
| 0.116 | 0.049 | 0.157 | Urease inhibitor | 0.133 0.033 DBMET01807 0.086 0.083 DBMET01565 0.157 0.02 DB03610 | DB03610 | |
| 0.117 | 0.05 | 0.207 | Nav1.1 sodium channel blocker | 0.207 0.018 DBMET01565 0.179 0.024 DB03610 | DBMET01565 | |
| 0.092 | 0.026 | 0.092 | Alpha 1d adrenoreceptor antagonist | 0.07 0.035 DBMET01565 | ||
| 0.13 | 0.065 | 0.183 | Vanilloid 1 agonist | 0.125 0.077 DBMET01807 0.183 0.017 DBMET01565 0.179 0.019 DB03610 | DBMET01565 | |
| 0.114 | 0.049 | 0.114 | Bronchodilator | |||
| 0.126 | 0.061 | 0.154 | Acetylcholine muscarinic antagonist | 0.11 0.079 DBMET01807 0.154 0.041 DBMET01565 | DBMET01565 | |
| 0.073 | 0.01 | 0.12 | Adenylate cyclase 1 inhibitor | 0.072 0.011 DBMET01807 0.059 0.018 DBMET01565 0.12 0.003 DB03610 | DB03610 | |
| 0.079 | 0.017 | 0.126 | Neurokinin antagonist | 0.085 0.015 DBMET01807 0.126 0.007 DB03610 | DB03610 | |
| 0.066 | 0.006 | 0.084 | Histamine H1 receptor agonist | 0.056 0.011 DBMET01807 0.084 0.003 DBMET01565 0.052 0.016 DB03610 | DBMET01565 | |
| 0.074 | 0.014 | 0.074 | Beta 2 adrenoreceptor agonist | 0.068 0.023 DBMET01807 0.072 0.017 DBMET01565 0.072 0.016 DB03610 | ||
| 0.098 | 0.04 | 0.194 | Acetylcholine nicotinic antagonist | 0.081 0.053 DBMET01807 0.194 0.013 DBMET01565 | DBMET01565 | |
| 0.073 | 0.016 | 0.085 | Epithelial sodium channel blocker | 0.084 0.011 DBMET01807 0.068 0.019 DBMET01565 0.085 0.011 DB03610 | DB03610 | |
| 0.188 | 0.131 | 0.242 | Cardiotonic | 0.242 0.088 DBMET01565 | DBMET01565 | |
| 0.113 | 0.057 | 0.113 | Electron transport complex I inhibitor | 0.096 0.091 DBMET01807 0.098 0.087 DB03610 | ||
| 0.064 | 0.008 | 0.074 | Diamine oxidase inhibitor | 0.074 0.006 DBMET01807 0.055 0.012 DBMET01565 0.033 0.032 DB03610 | DBMET01807 | |
| 0.102 | 0.047 | 0.173 | ABCA1 expression enhancer | 0.087 0.071 DBMET01807 0.173 0.013 DB03610 | DB03610 | |
| 0.095 | 0.04 | 0.194 | Histamine H2 receptor antagonist | 0.194 0.005 DBMET01565 | DBMET01565 | |
| 0.081 | 0.026 | 0.082 | Acetylcholine M3 receptor antagonist | 0.062 0.039 DBMET01807 0.082 0.025 DBMET01565 | DBMET01565 | |
| 0.229 | 0.175 | 0.568 | GABA C receptor rho-3 antagonist | 0.258 0.147 DBMET01807 0.477 0.032 DBMET01565 0.568 0.011 DB03610 | DB03610 | |
| 0.101 | 0.047 | 0.106 | Calcium antagonist | 0.088 0.057 DBMET01807 0.106 0.044 DBMET01565 0.073 0.07 DB03610 | DBMET01565 | |
| 0.095 | 0.042 | 0.189 | Myeloperoxidase inhibitor | 0.11 0.026 DBMET01807 0.098 0.038 DBMET01565 0.189 0.006 DB03610 | DB03610 | |
| 0.065 | 0.013 | 0.081 | Cholesterol esterase inhibitor | 0.053 0.026 DBMET01565 0.081 0.007 DB03610 | DB03610 | |
| 0.085 | 0.034 | 0.1 | Amidase inhibitor | 0.1 0.024 DBMET01565 0.096 0.027 DB03610 | DBMET01565 | |
| 0.06 | 0.011 | 0.083 | Alpha 1d adrenoreceptor agonist | 0.058 0.012 DBMET01807 0.051 0.016 DBMET01565 0.083 0.005 DB03610 | DB03610 | |
| 0.06 | 0.012 | 0.085 | Substance P antagonist | 0.068 0.009 DBMET01807 0.085 0.007 DB03610 | DB03610 | |
| 0.225 | 0.176 | 0.494 | Histamine release inhibitor | 0.303 0.122 DBMET01807 0.427 0.061 DBMET01565 0.494 0.031 DB03610 | DB03610 | |
| 0.11 | 0.063 | 0.262 | GABA C receptor antagonist | 0.19 0.015 DBMET01807 0.188 0.015 DBMET01565 0.262 0.005 DB03610 | DB03610 | |
| 0.052 | 0.005 | 0.055 | Ceramide glucosyltransferase inhibitor | 0.043 0.013 DBMET01807 0.048 0.008 DBMET01565 0.055 0.005 DB03610 | DB03610 | |
| 0.212 | 0.166 | 0.241 | Ca(v)3.3 blocker | 0.241 0.115 DBMET01565 | DBMET01565 | |
| 0.095 | 0.05 | 0.248 | Androgen antagonist | 0.084 0.061 DBMET01807 0.248 0.009 DB03610 | DB03610 | |
| 0.086 | 0.042 | 0.086 | Alpha 1a adrenoreceptor antagonist | |||
| 0.073 | 0.029 | 0.073 | Alpha 2 adrenoreceptor agonist | 0.056 0.048 DBMET01807 0.064 0.038 DBMET01565 0.053 0.052 DB03610 | ||
| 0.115 | 0.072 | 0.191 | Beta amyloid protein antagonist | 0.14 0.048 DBMET01807 0.191 0.02 DB03610 | DB03610 | |
| 0.06 | 0.017 | 0.063 | Stearoyl-CoA desaturase inhibitor | 0.063 0.016 DB03610 | DB03610 | |
| 0.151 | 0.113 | 0.339 | Anesthetic general | 0.166 0.098 DBMET01807 0.28 0.039 DBMET01565 0.339 0.025 DB03610 | DB03610 | |
| 0.158 | 0.121 | 0.159 | MAP kinase kinase 5 inhibitor | 0.156 0.13 DBMET01807 0.159 0.12 DB03610 | DB03610 | |
| 0.049 | 0.012 | 0.073 | Delayed rectifier potassium channel blocker | 0.036 0.028 DBMET01807 0.061 0.007 DBMET01565 0.073 0.005 DB03610 | DB03610 | |
| 0.12 | 0.084 | 0.144 | Toll-Like receptor antagonist | 0.119 0.086 DBMET01565 0.144 0.06 DB03610 | DB03610 | |
| 0.076 | 0.04 | 0.153 | Neuronal nicotinic receptor antagonist | 0.063 0.051 DBMET01807 0.153 0.012 DBMET01565 | DBMET01565 | |
| 0.056 | 0.02 | 0.056 | Potassium channel small-conductance Ca-activated blocker | 0.043 0.034 DB03610 | ||
| 0.137 | 0.1 | 0.137 | Polo-like kinase-3 inhibitor | 0.134 0.104 DBMET01807 | ||
| 0.059 | 0.023 | 0.072 | Lysophosphatidic acid 3 receptor antagonist | 0.062 0.021 DBMET01807 0.072 0.013 DB03610 | DB03610 | |
| 0.175 | 0.14 | 0.3 | Nitric-oxide synthase stimulant | 0.192 0.103 DBMET01807 0.234 0.045 DBMET01565 0.3 0.011 DB03610 | DB03610 | |
| 0.075 | 0.041 | 0.217 | Phenylalanine 4-hydroxylase inhibitor | 0.112 0.021 DBMET01807 0.119 0.018 DBMET01565 0.217 0.006 DB03610 | DB03610 | |
| 0.066 | 0.032 | 0.109 | Heme oxygenase stimulant | 0.058 0.052 DBMET01807 0.057 0.054 DBMET01565 0.109 0.005 DB03610 | DB03610 | |
| 0.055 | 0.021 | 0.079 | NMDA receptor subunit 3B antagonist | 0.06 0.019 DBMET01807 0.079 0.014 DB03610 | DB03610 | |
| 0.037 | 0.005 | 0.037 | Alpha 2a adrenoreceptor agonist | 0.029 0.005 DBMET01807 0.016 0.013 DBMET01565 0.03 0.005 DB03610 | ||
| 0.184 | 0.152 | 0.267 | Neuropeptide Y2 antagonist | 0.232 0.074 DBMET01807 0.229 0.078 DBMET01565 0.267 0.04 DB03610 | DB03610 | |
| 0.112 | 0.081 | 0.187 | Cholinergic antagonist | 0.187 0.036 DBMET01565 | DBMET01565 | |
| 0.074 | 0.043 | 0.074 | Toll-Like receptor 7 antagonist | |||
| 0.064 | 0.033 | 0.064 | 5 Hydroxytryptamine 6 antagonist | 0.053 0.044 DBMET01807 | ||
| 0.047 | 0.016 | 0.05 | Glucagon-like peptide 1 receptor antagonist | 0.05 0.013 DBMET01807 0.039 0.028 DB03610 | DBMET01807 | |
| 0.035 | 0.006 | 0.041 | 1,3-Beta-glucan synthase inhibitor | 0.041 0.004 DBMET01807 | DBMET01807 | |
| 0.036 | 0.008 | 0.062 | Estrogen-related receptor gamma antagonist | 0.028 0.019 DBMET01807 0.039 0.006 DBMET01565 0.062 0.002 DB03610 | DB03610 | |
| 0.057 | 0.03 | 0.078 | 5 Hydroxytryptamine 1B agonist | 0.078 0.013 DBMET01565 | DBMET01565 | |
| 0.096 | 0.069 | 0.158 | Anabolic | 0.109 0.05 DBMET01807 0.103 0.058 DBMET01565 0.158 0.014 DB03610 | DB03610 | |
| 0.057 | 0.03 | 0.06 | 5 Hydroxytryptamine 2 agonist | 0.056 0.031 DBMET01807 0.06 0.027 DB03610 | DB03610 | |
| 0.108 | 0.082 | 0.179 | Acetylcholine antagonist | 0.179 0.037 DBMET01565 | DBMET01565 | |
| 0.032 | 0.007 | 0.035 | Acid ceramidase inhibitor | 0.025 0.02 DBMET01807 0.035 0.005 DBMET01565 0.025 0.02 DB03610 | DBMET01565 | |
| 0.111 | 0.087 | 0.261 | Acetylcholinesterase inhibitor | 0.261 0.018 DBMET01565 | DBMET01565 | |
| 0.046 | 0.022 | 0.065 | NMDA receptor subunit 3A antagonist | 0.048 0.021 DBMET01807 0.065 0.015 DB03610 | DB03610 | |
| 0.062 | 0.039 | 0.094 | Carbonic anhydrase stimulant | 0.059 0.041 DBMET01807 0.094 0.02 DBMET01565 | DBMET01565 | |
| 0.047 | 0.024 | 0.089 | Histamine H2 receptor agonist | 0.089 0.005 DBMET01565 | DBMET01565 | |
| 0.047 | 0.025 | 0.048 | Beta adrenoreceptor agonist | 0.046 0.029 DBMET01565 0.048 0.023 DB03610 | DB03610 | |
| 0.146 | 0.124 | 0.258 | P-glycoprotein inhibitor | 0.258 0.039 DBMET01565 | DBMET01565 | |
| 0.049 | 0.028 | 0.071 | Oleamide hydrolase inhibitor | 0.071 0.015 DBMET01565 0.048 0.029 DB03610 | DBMET01565 | |
| 0.04 | 0.021 | 0.05 | Nociceptin (N/OFQ) receptor antagonist | 0.05 0.014 DBMET01807 | DBMET01807 | |
| 0.153 | 0.134 | 0.213 | Growth factor agonist | 0.17 0.102 DBMET01565 0.213 0.052 DB03610 | DB03610 | |
| 0.063 | 0.045 | 0.075 | 5 Hydroxytryptamine 1D antagonist | 0.075 0.034 DBMET01565 | DBMET01565 | |
| 0.052 | 0.037 | 0.097 | Histamine agonist | 0.097 0.009 DBMET01565 | DBMET01565 | |
| 0.024 | 0.009 | 0.031 | Factor IX inhibitor | 0.031 0.005 DBMET01807 | DBMET01807 | |
| 0.063 | 0.048 | 0.063 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.05 | 0.035 | 0.05 | Alpha 1b adrenoreceptor agonist | |||
| 0.124 | 0.11 | 0.203 | Phospholipase A2 inhibitor | 0.192 0.047 DBMET01807 0.16 0.065 DBMET01565 0.203 0.041 DB03610 | DB03610 | |
| 0.069 | 0.055 | 0.087 | Peroxisome proliferator-activated receptor gamma antagonist | 0.067 0.06 DBMET01807 0.087 0.025 DB03610 | DB03610 | |
| 0.022 | 0.009 | 0.022 | Alpha 2c adrenoreceptor agonist | 0.017 0.016 DBMET01807 | ||
| 0.103 | 0.09 | 0.132 | Calcium channel N-type blocker | 0.132 0.05 DB03610 | DB03610 | |
| 0.036 | 0.024 | 0.046 | Tryptophan 5 hydroxylase inhibitor | 0.046 0.007 DBMET01807 0.045 0.009 DB03610 | DBMET01807 | |
| 0.101 | 0.089 | 0.238 | MAO inhibitor | 0.107 0.083 DBMET01807 0.238 0.03 DBMET01565 0.194 0.042 DB03610 | DBMET01565 | |
| 0.103 | 0.092 | 0.182 | Glutamate receptor antagonist | 0.182 0.032 DBMET01807 0.104 0.092 DB03610 | DBMET01807 | |
| 0.047 | 0.037 | 0.061 | Cytokine production stimulant | 0.061 0.012 DBMET01807 0.045 0.043 DBMET01565 | DBMET01807 | |
| 0.026 | 0.016 | 0.027 | Lysophosphatidic acid receptor 1 agonist | 0.025 0.017 DBMET01807 0.024 0.019 DBMET01565 0.027 0.015 DB03610 | DB03610 | |
| 0.048 | 0.039 | 0.07 | Squalene epoxidase inhibitor | 0.067 0.015 DBMET01565 0.07 0.014 DB03610 | DB03610 | |
| 0.063 | 0.055 | 0.444 | Potassium channel large-conductance Ca-activated activator | 0.444 0.004 DB03610 | DB03610 | |
| 0.057 | 0.05 | 0.106 | 5 Hydroxytryptamine 2A agonist | 0.079 0.029 DBMET01807 0.077 0.03 DBMET01565 0.106 0.012 DB03610 | DB03610 | |
| 0.11 | 0.104 | 0.249 | Protein kinase stimulant | 0.156 0.064 DBMET01807 0.178 0.051 DBMET01565 0.249 0.027 DB03610 | DB03610 | |
| 0.056 | 0.05 | 0.056 | Potassium channel (Ca-activated) blocker | |||
| 0.162 | 0.156 | 0.245 | Interleukin agonist | 0.242 0.085 DBMET01807 0.244 0.083 DBMET01565 0.245 0.083 DB03610 | DB03610 | |
| 0.054 | 0.049 | 0.103 | Pregnane X receptor antagonist | 0.058 0.035 DBMET01807 0.103 0.003 DB03610 | DB03610 | |
| 0.18 | 0.176 | 0.435 | Tyrosine 3 hydroxylase inhibitor | 0.227 0.094 DBMET01807 0.347 0.017 DBMET01565 0.435 0.005 DB03610 | DB03610 | |
| 0.067 | 0.064 | 0.15 | CYP2A6 inhibitor | 0.099 0.036 DBMET01807 0.15 0.016 DBMET01565 0.139 0.02 DB03610 | DBMET01565 | |
| 0.053 | 0.05 | 0.089 | Sphingosine 1-phosphate receptor 3 antagonist | 0.054 0.049 DBMET01807 0.072 0.024 DBMET01565 0.089 0.012 DB03610 | DB03610 | |
| 0.055 | 0.053 | 0.121 | Potassium channel intermediate-conductance Ca-activated blocker | 0.07 0.027 DBMET01807 0.121 0.005 DB03610 | DB03610 | |
| 0.075 | 0.073 | 0.123 | Ornithine decarboxylase inhibitor | 0.106 0.038 DBMET01807 0.123 0.024 DBMET01565 0.117 0.028 DB03610 | DBMET01565 | |
| 0.165 | 0.163 | 0.559 | Superoxide dismutase inhibitor | 0.351 0.036 DBMET01807 0.487 0.014 DBMET01565 0.559 0.009 DB03610 | DB03610 | |
| 0.042 | 0.04 | 0.042 | Proto-oncogene tyrosine-protein kinase Met inhibitor | |||
| 0.073 | 0.072 | 0.235 | Ca(v)2.2 blocker | 0.235 0.012 DB03610 | DB03610 | |
| 0.025 | 0.026 | 0.037 | Thrombin receptor antagonist | 0.029 0.019 DBMET01807 0.037 0.013 DBMET01565 | DBMET01565 | |
| 0.017 | 0.018 | 0.029 | Estrogen-related receptor gamma agonist | 0.025 0.005 DBMET01565 0.029 0.004 DB03610 | DB03610 | |
| 0.183 | 0.185 | 0.329 | Insulysin inhibitor | 0.198 0.16 DBMET01807 0.316 0.049 DBMET01565 0.329 0.043 DB03610 | DB03610 | |
| 0.016 | 0.02 | 0.02 | Alpha 2b adrenoreceptor agonist | 0.019 0.012 DBMET01807 0.02 0.01 DB03610 | DB03610 | |
| 0.095 | 0.099 | 0.157 | Acetylcholine release stimulant | 0.157 0.013 DBMET01565 0.101 0.084 DB03610 | DBMET01565 | |
| 0.037 | 0.042 | 0.087 | Nerve growth factor antagonist | 0.087 0.004 DB03610 | DB03610 | |
| 0.121 | 0.126 | 0.189 | Pregnane X receptor agonist | 0.123 0.119 DBMET01807 0.189 0.014 DB03610 | DB03610 | |
| 0.035 | 0.041 | 0.054 | Sphingosine 1-phosphate receptor 1 agonist | 0.041 0.032 DBMET01807 0.054 0.016 DB03610 | DB03610 | |
| 0.071 | 0.077 | 0.126 | Bcr-Abl kinase inhibitor | 0.126 0.023 DB03610 | DB03610 | |
| 0.008 | 0.014 | 0.01 | Imidazoline I2 receptor antagonist | 0.01 0.008 DBMET01807 | DBMET01807 | |
| 0.026 | 0.033 | 0.068 | Cholesterol ester transfer protein antagonist | 0.034 0.018 DBMET01807 0.068 0.004 DB03610 | DB03610 | |
| 0.058 | 0.066 | 0.086 | Calcium channel P-type blocker | 0.062 0.048 DBMET01807 0.086 0.011 DB03610 | DB03610 | |
| 0.04 | 0.048 | 0.074 | NMDA 2A receptor antagonist | 0.057 0.032 DBMET01565 0.074 0.022 DB03610 | DB03610 | |
| 0.053 | 0.061 | 0.106 | 5 Hydroxytryptamine 5A antagonist | 0.106 0.014 DBMET01565 0.056 0.054 DB03610 | DBMET01565 | |
| 0.028 | 0.037 | 0.051 | Melatonin receptor 1A agonist | 0.051 0.007 DBMET01565 | DBMET01565 | |
| 0.024 | 0.034 | 0.045 | Lysophosphatidic acid 2 receptor antagonist | 0.032 0.019 DBMET01565 0.045 0.01 DB03610 | DB03610 | |
| 0.029 | 0.039 | 0.144 | Kinesin-like protein 1 inhibitor | 0.139 0.005 DBMET01807 0.144 0.005 DB03610 | DB03610 | |
| 0.029 | 0.039 | 0.144 | Kinesin antagonist | 0.139 0.005 DBMET01807 0.144 0.005 DB03610 | DB03610 | |
| 0.03 | 0.04 | 0.043 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.043 0.017 DB03610 | DB03610 | |
| 0.046 | 0.057 | 0.136 | Sphingosine kinase 2 inhibitor | 0.074 0.019 DBMET01807 0.136 0.004 DB03610 | DB03610 | |
| 0.009 | 0.019 | 0.012 | CD80 antagonist | 0.012 0.005 DB03610 | DB03610 | |
| 0.084 | 0.096 | 0.289 | Carbonic anhydrase XV inhibitor | 0.167 0.025 DBMET01807 0.1 0.067 DBMET01565 0.289 0.009 DB03610 | DB03610 | |
| 0.049 | 0.06 | 0.102 | 5 Hydroxytryptamine 5 antagonist | 0.102 0.015 DBMET01565 | DBMET01565 | |
| 0.008 | 0.02 | 0.015 | Lysophosphatidic acid receptor 3 agonist | 0.013 0.01 DBMET01807 0.015 0.008 DB03610 | DB03610 | |
| 0.055 | 0.067 | 0.088 | Nav1.7 sodium channel blocker | 0.088 0.028 DB03610 | DB03610 | |
| 0.086 | 0.099 | 0.199 | Adenylate kinase inhibitor | 0.107 0.057 DBMET01807 0.126 0.039 DBMET01565 0.199 0.015 DB03610 | DB03610 | |
| 0.017 | 0.03 | 0.021 | Beta 1 adrenoreceptor agonist | 0.021 0.019 DB03610 | DB03610 | |
| 0.011 | 0.025 | 0.02 | KiSS-1 receptor antagonist | 0.02 0.009 DBMET01565 | DBMET01565 | |
| 0.027 | 0.042 | 0.04 | Vanilloid 4 antagonist | 0.04 0.012 DB03610 | DB03610 | |
| 0.013 | 0.028 | 0.019 | 5-Alpha-reductase 2 inhibitor | 0.019 0.014 DB03610 | DB03610 | |
| 0.035 | 0.05 | 0.079 | CF transmembrane conductance regulator antagonist | 0.079 0.003 DB03610 | DB03610 | |
| 0.014 | 0.03 | 0.029 | Imidazoline I1 receptor antagonist | 0.029 0.007 DBMET01807 | DBMET01807 | |
| 0.017 | 0.032 | 0.048 | Prostaglandin F2 alpha agonist | 0.048 0.004 DB03610 | DB03610 | |
| 0.019 | 0.035 | 0.03 | Urotensin II agonist | 0.03 0.015 DBMET01807 | DBMET01807 | |
| 0.04 | 0.057 | 0.063 | Toll-Like receptor 8 antagonist | 0.063 0.028 DBMET01807 | DBMET01807 | |
| 0.031 | 0.049 | 0.081 | Histone deacetylase 9 inhibitor | 0.081 0.008 DBMET01565 | DBMET01565 | |
| 0.116 | 0.135 | 0.231 | GABA C receptor rho-2 antagonist | 0.231 0.016 DBMET01565 0.214 0.022 DB03610 | DBMET01565 | |
| 0.018 | 0.037 | 0.033 | ICAM 1 antagonist | 0.033 0.005 DB03610 | DB03610 | |
| 0.008 | 0.027 | 0.023 | Microsomal triglyceride transfer protein inhibitor | 0.023 0.006 DB03610 | DB03610 | |
| 0.068 | 0.087 | 0.171 | MAO B inhibitor | 0.094 0.063 DBMET01807 0.153 0.036 DBMET01565 0.171 0.031 DB03610 | DB03610 | |
| 0.047 | 0.067 | 0.095 | Sphingosine 1-phosphate receptor 1 antagonist | 0.095 0.01 DB03610 | DB03610 | |
| 0.033 | 0.053 | 0.057 | Sphingosine 1-phosphate receptor agonist | 0.057 0.019 DB03610 | DB03610 | |
| 0.049 | 0.071 | 0.096 | NMDA receptor agonist | 0.059 0.048 DBMET01807 0.096 0.021 DBMET01565 0.088 0.024 DB03610 | DBMET01565 | |
| 0.021 | 0.043 | 0.058 | Purinergic P2Y14 antagonist | 0.035 0.015 DBMET01807 0.058 0.005 DB03610 | DB03610 | |
| 0.042 | 0.064 | 0.065 | Alpha-mannosidase inhibitor | 0.065 0.022 DBMET01565 0.064 0.022 DB03610 | DBMET01565 | |
| 0.059 | 0.082 | 0.101 | Phospholipase D inhibitor | 0.101 0.014 DBMET01565 0.086 0.026 DB03610 | DBMET01565 | |
| 0.023 | 0.047 | 0.039 | 5-Alpha-reductase inhibitor | 0.039 0.025 DB03610 | DB03610 | |
| 0.083 | 0.107 | 0.166 | Mucolytic | 0.125 0.05 DBMET01807 0.109 0.066 DBMET01565 0.166 0.024 DB03610 | DB03610 | |
| 0.071 | 0.096 | 0.173 | Potassium channel activator | 0.173 0.013 DB03610 | DB03610 | |
| 0.067 | 0.093 | 0.364 | Potassium channel (Ca-activated) activator | 0.082 0.073 DBMET01565 0.364 0.004 DB03610 | DB03610 | |
| 0.063 | 0.089 | 0.097 | Vanilloid 4 agonist | 0.097 0.019 DBMET01565 0.084 0.034 DB03610 | DBMET01565 | |
| 0.03 | 0.057 | 0.051 | 5 Hydroxytryptamine 2B agonist | 0.046 0.016 DBMET01807 0.051 0.013 DB03610 | DB03610 | |
| 0.054 | 0.082 | 0.129 | Glutamate (mGluR7) antagonist | 0.073 0.037 DBMET01807 0.129 0.004 DB03610 | DB03610 | |
| 0.077 | 0.106 | 0.187 | GABA C receptor rho-1 antagonist | 0.113 0.047 DBMET01807 0.187 0.01 DBMET01565 0.152 0.02 DB03610 | DBMET01565 | |
| 0.016 | 0.045 | 0.098 | Liver X receptor beta antagonist | 0.098 0.004 DB03610 | DB03610 | |
| 0.014 | 0.044 | 0.027 | Protease (Human cytomegalovirus) inhibitor | 0.022 0.016 DBMET01565 0.027 0.01 DB03610 | DB03610 | |
| 0.04 | 0.071 | 0.056 | Leukotriene B4 antagonist | 0.056 0.034 DB03610 | DB03610 | |
| 0.037 | 0.068 | 0.047 | Benzodiazepine antagonist | 0.047 0.034 DBMET01565 | DBMET01565 | |
| 0.029 | 0.06 | 0.071 | Peroxisome proliferator-activated receptor alpha agonist | 0.071 0.022 DB03610 | DB03610 | |
| 0.044 | 0.075 | 0.068 | 5 Hydroxytryptamine 7 agonist | 0.068 0.021 DBMET01565 0.068 0.021 DB03610 | DB03610 | |
| 0.031 | 0.062 | 0.111 | Liver X receptor agonist | 0.111 0.006 DB03610 | DB03610 | |
| 0.018 | 0.049 | 0.032 | Vanilloid 2 agonist | 0.032 0.007 DBMET01565 0.03 0.009 DB03610 | DBMET01565 | |
| 0.026 | 0.058 | 0.064 | Oxytocin agonist | 0.05 0.024 DBMET01565 0.064 0.014 DB03610 | DB03610 | |
| 0.055 | 0.088 | 0.125 | Nicotinic alpha4beta2 receptor antagonist | 0.125 0.015 DBMET01565 0.077 0.053 DB03610 | DBMET01565 | |
| 0.025 | 0.059 | 0.066 | Vascular adhesion protein 1 inhibitor | 0.066 0.007 DBMET01807 | DBMET01807 | |
| 0.002 | 0.037 | 0.007 | CC chemokine 6 receptor agonist | 0.007 0.004 DB03610 | DB03610 | |
| 0.03 | 0.065 | 0.064 | Potassium channel Kv1.3 blocker | 0.046 0.033 DBMET01565 0.064 0.019 DB03610 | DB03610 | |
| 0.063 | 0.099 | 0.125 | GABA B receptor agonist | 0.107 0.012 DBMET01807 0.102 0.015 DBMET01565 0.125 0.006 DB03610 | DB03610 | |
| 0.063 | 0.099 | 0.117 | Sphingosine 1-phosphate receptor antagonist | 0.117 0.014 DB03610 | DB03610 | |
| 0.017 | 0.054 | 0.034 | LFA antagonist | 0.034 0.012 DB03610 | DB03610 | |
| 0.017 | 0.053 | 0.038 | Endothelial nitric-oxide synthase inhibitor | 0.038 0.015 DBMET01565 | DBMET01565 | |
| 0.006 | 0.043 | 0.024 | Peroxisome proliferator-activated receptor alpha antagonist | 0.024 0.014 DB03610 | DB03610 | |
| 0.03 | 0.066 | 0.053 | Mannosidase inhibitor | 0.05 0.025 DBMET01565 0.053 0.022 DB03610 | DB03610 | |
| 0.064 | 0.101 | 0.133 | Glutathione S-transferase inhibitor | 0.093 0.045 DBMET01565 0.133 0.017 DB03610 | DB03610 | |
| 0.025 | 0.062 | 0.064 | Neurokinin 3 antagonist | 0.064 0.017 DB03610 | DB03610 | |
| 0.058 | 0.095 | 0.105 | Protein kinase A inhibitor | 0.105 0.042 DBMET01807 | DBMET01807 | |
| 0.019 | 0.059 | 0.032 | Purinergic P2Y15 antagonist | 0.032 0.014 DBMET01565 0.028 0.021 DB03610 | DBMET01565 | |
| 0.064 | 0.105 | 0.187 | 5-Lipoxygenase inhibitor | 0.187 0.027 DB03610 | DB03610 | |
| 0.044 | 0.085 | 0.085 | Dopamine antagonist | 0.085 0.045 DBMET01565 | DBMET01565 | |
| 0.024 | 0.066 | 0.048 | Erythropoietin receptor agonist | 0.048 0.023 DB03610 | DB03610 | |
| 0.026 | 0.069 | 0.118 | Liver X receptor alpha agonist | 0.118 0.005 DB03610 | DB03610 | |
| 0.037 | 0.08 | 0.055 | Dopamine D3 antagonist | 0.055 0.05 DBMET01565 | DBMET01565 | |
| 0.079 | 0.123 | 0.292 | M18 aspartyl aminopeptidase inhibitor | 0.292 0.014 DB03610 | DB03610 | |
| 0.009 | 0.053 | 0.029 | Dopamine autoreceptor agonist | 0.029 0.014 DBMET01565 | DBMET01565 | |
| 0.041 | 0.085 | 0.105 | Acetylcholine M5 receptor agonist | 0.105 0.017 DB03610 | DB03610 | |
| 0.087 | 0.132 | 0.232 | Toll-Like receptor 2 antagonist | 0.146 0.055 DBMET01807 0.124 0.074 DBMET01565 0.232 0.013 DB03610 | DB03610 | |
| 0.123 | 0.168 | 0.201 | Heat shock protein 70 antagonist | 0.14 0.076 DBMET01807 0.133 0.104 DBMET01565 0.201 0.006 DB03610 | DB03610 | |
| 0.064 | 0.11 | 0.233 | HIV-1 integrase (Overall Integration) inhibitor | 0.143 0.028 DBMET01807 0.163 0.021 DBMET01565 0.233 0.006 DB03610 | DB03610 | |
| 0.007 | 0.054 | 0.014 | Melatonin receptor 1A antagonist | 0.014 0.01 DBMET01565 | DBMET01565 | |
| 0.153 | 0.199 | 0.294 | Lipoxygenase inhibitor | 0.183 0.159 DBMET01565 0.294 0.074 DB03610 | DB03610 | |
| 0.067 | 0.114 | 0.111 | Ca(v)3.1 blocker | 0.111 0.014 DB03610 | DB03610 | |
| 0.013 | 0.06 | 0.025 | Glutaminyl-peptide cyclotransferase inhibitor | 0.025 0.01 DBMET01565 | DBMET01565 | |
| 0.017 | 0.065 | 0.074 | Liver X receptor alpha antagonist | 0.074 0.004 DB03610 | DB03610 | |
| 0.032 | 0.08 | 0.099 | Acyl-CoA dehydrogenase inhibitor | 0.099 0.016 DBMET01565 0.085 0.02 DB03610 | DBMET01565 | |
| 0.04 | 0.089 | 0.15 | Dihydroorotate oxidase inhibitor | 0.15 0.003 DB03610 | DB03610 | |
| 0.01 | 0.059 | 0.034 | Sigma 2 receptor antagonist | 0.034 0.015 DBMET01565 | DBMET01565 | |
| 0.11 | 0.159 | 0.291 | Melanin inhibitor | 0.147 0.086 DBMET01807 0.133 0.108 DBMET01565 0.291 0.023 DB03610 | DB03610 | |
| 0.046 | 0.095 | 0.134 | Aryl hydrocarbon receptor antagonist | 0.063 0.048 DBMET01565 0.134 0.006 DB03610 | DB03610 | |
| 0.015 | 0.065 | 0.053 | Peroxisome proliferator-activated receptor delta agonist | 0.053 0.012 DB03610 | DB03610 | |
| 0.034 | 0.084 | 0.074 | Potassium channel (ATP-sensitive) activator | 0.074 0.008 DB03610 | DB03610 | |
| 0.067 | 0.117 | 0.111 | mTOR complex 2 inhibitor | 0.111 0.023 DB03610 | DB03610 | |
| 0.018 | 0.068 | 0.087 | Liver X receptor beta agonist | 0.087 0.005 DB03610 | DB03610 | |
| 0.014 | 0.065 | 0.053 | Sirtuin 2 inhibitor | 0.053 0.012 DBMET01565 0.032 0.023 DB03610 | DBMET01565 | |
| 0.016 | 0.066 | 0.028 | Calcium-sensing receptor agonist | 0.028 0.017 DB03610 | DB03610 | |
| 0.035 | 0.086 | 0.077 | Potassium channel (Inward rectifier) activator | 0.077 0.009 DB03610 | DB03610 | |
| 0.137 | 0.188 | 0.302 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.165 0.116 DBMET01807 0.162 0.122 DBMET01565 0.302 0.023 DB03610 | DB03610 | |
| 0.026 | 0.078 | 0.06 | Potassium channel Kv1.1 blocker | 0.038 0.026 DBMET01565 0.06 0.009 DB03610 | DB03610 | |
| 0.082 | 0.133 | 0.101 | Factor V inhibitor | 0.101 0.067 DBMET01565 | DBMET01565 | |
| 0.079 | 0.131 | 0.198 | Cyclooxygenase 1 inhibitor | 0.198 0.035 DB03610 | DB03610 | |
| 0.03 | 0.082 | 0.104 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.044 0.023 DBMET01565 0.104 0.003 DB03610 | DB03610 | |
| 0.008 | 0.061 | 0.017 | Histamine H4 receptor agonist | 0.017 0.015 DBMET01565 | DBMET01565 | |
| 0.095 | 0.148 | 0.252 | Cholinergic | 0.252 0.028 DBMET01565 | DBMET01565 | |
| 0.064 | 0.117 | 0.099 | Aminoacyl-tRNA synthetase inhibitor | 0.099 0.046 DBMET01807 | DBMET01807 | |
| 0.039 | 0.092 | 0.158 | NMDA 2 receptor antagonist | 0.076 0.046 DBMET01807 0.158 0.015 DB03610 | DB03610 | |
| 0.065 | 0.119 | 0.419 | Creatine kinase inhibitor | 0.113 0.046 DBMET01807 0.104 0.056 DBMET01565 0.419 0.003 DB03610 | DB03610 | |
| 0.069 | 0.124 | 0.116 | Potassium channel (Voltage-sensitive) activator | 0.085 0.079 DBMET01565 0.116 0.035 DB03610 | DB03610 | |
| 0.056 | 0.111 | 0.082 | Opioid kappa receptor antagonist | 0.082 0.055 DB03610 | DB03610 | |
| 0.081 | 0.136 | 0.17 | Photosensitizer | 0.103 0.083 DBMET01807 0.12 0.057 DBMET01565 0.17 0.021 DB03610 | DB03610 | |
| 0.031 | 0.087 | 0.053 | Potassium channel (Inward rectifier) blocker | 0.053 0.03 DBMET01565 0.044 0.042 DB03610 | DBMET01565 | |
| 0.038 | 0.094 | 0.064 | Bombesin 1 receptor agonist | 0.064 0.037 DBMET01565 | DBMET01565 | |
| 0.082 | 0.138 | 0.317 | Aldehyde dehydrogenase inhibitor | 0.106 0.089 DBMET01807 0.16 0.042 DBMET01565 0.317 0.01 DB03610 | DB03610 | |
| 0.031 | 0.088 | 0.072 | Dopamine D2 antagonist | 0.072 0.043 DBMET01565 | DBMET01565 | |
| 0.021 | 0.078 | 0.061 | Peroxisome proliferator-activated receptor delta antagonist | 0.061 0.008 DB03610 | DB03610 | |
| 0.013 | 0.07 | 0.029 | Prostaglandin EP4 antagonist | 0.029 0.016 DB03610 | DB03610 | |
| 0.034 | 0.092 | 0.044 | Heme oxygenase inhibitor | 0.044 0.026 DBMET01565 0.044 0.025 DB03610 | DB03610 | |
| 0.006 | 0.063 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.012 0.011 DBMET01565 0.015 0.006 DB03610 | DB03610 | |
| 0.004 | 0.063 | 0.011 | Integrin beta2 antagonist | 0.011 0.01 DB03610 | DB03610 | |
| 0.014 | 0.074 | 0.102 | Liver X receptor antagonist | 0.102 0.005 DB03610 | DB03610 | |
| 0.035 | 0.095 | 0.152 | Androgen agonist | 0.152 0.007 DB03610 | DB03610 | |
| 0.004 | 0.066 | 0.022 | Prostaglandin EP4 agonist | 0.022 0.008 DB03610 | DB03610 | |
| 0.072 | 0.136 | 0.153 | Alkylator | 0.153 0.045 DBMET01565 | DBMET01565 | |
| 0.016 | 0.08 | 0.032 | Calcitonin receptor agonist | 0.032 0.025 DB03610 | DB03610 | |
| 0.049 | 0.113 | 0.108 | Transcription factor RelA inhibitor | 0.065 0.039 DBMET01807 0.108 0.005 DB03610 | DB03610 | |
| 0.062 | 0.126 | 0.171 | Gastric antisecretory | 0.171 0.019 DBMET01565 | DBMET01565 | |
| 0.037 | 0.1 | 0.12 | Nicotinic alpha3beta2 receptor antagonist | 0.12 0.005 DBMET01565 0.056 0.031 DB03610 | DBMET01565 | |
| 0.02 | 0.084 | 0.034 | Delayed rectifier potassium channel activator | 0.034 0.029 DB03610 | DB03610 | |
| 0.02 | 0.084 | 0.034 | Potassium channel KCNQ activator | 0.034 0.029 DB03610 | DB03610 | |
| 0.054 | 0.119 | 0.185 | MAO A inhibitor | 0.185 0.032 DBMET01565 0.128 0.049 DB03610 | DBMET01565 | |
| 0.063 | 0.128 | 0.15 | Expectorant | 0.096 0.073 DBMET01807 0.15 0.035 DB03610 | DB03610 | |
| 0.044 | 0.108 | 0.077 | Immunoglobulin Fc receptor antagonist | 0.077 0.007 DBMET01565 0.058 0.029 DB03610 | DBMET01565 | |
| 0.029 | 0.095 | 0.077 | Acetylcholine M2 receptor antagonist | 0.077 0.032 DBMET01565 | DBMET01565 | |
| 0.011 | 0.077 | 0.033 | Nicotinic alpha4beta2 receptor agonist | 0.033 0.014 DBMET01565 | DBMET01565 | |
| 0.029 | 0.094 | 0.083 | GABA B receptor antagonist | 0.066 0.01 DBMET01807 0.083 0.006 DB03610 | DB03610 | |
| 0.078 | 0.144 | 0.183 | TRPA1 agonist | 0.111 0.069 DBMET01565 0.183 0.015 DB03610 | DB03610 | |
| 0.072 | 0.138 | 0.138 | Nav1.4 sodium channel blocker | 0.138 0.039 DBMET01807 0.099 0.078 DB03610 | DBMET01807 | |
| 0.013 | 0.08 | 0.061 | Retinoid X receptor agonist | 0.061 0.013 DB03610 | DB03610 | |
| 0.007 | 0.074 | 0.04 | Sigma 1 receptor antagonist | 0.04 0.013 DBMET01565 | DBMET01565 | |
| 0.083 | 0.15 | 0.183 | Interleukin 8 antagonist | 0.126 0.054 DBMET01565 0.183 0.018 DB03610 | DB03610 | |
| 0.016 | 0.084 | 0.104 | TRPM8 blocker | 0.057 0.013 DBMET01807 0.104 0.006 DB03610 | DB03610 | |
| 0.035 | 0.103 | 0.082 | Peroxisome proliferator-activated receptor gamma agonist | 0.082 0.039 DB03610 | DB03610 | |
| 0.044 | 0.113 | 0.106 | Aminopeptidase I inhibitor | 0.104 0.026 DBMET01565 0.106 0.025 DB03610 | DB03610 | |
| 0.061 | 0.13 | 0.203 | Triose-phosphate isomerase inhibitor | 0.082 0.072 DBMET01807 0.108 0.041 DBMET01565 0.203 0.01 DB03610 | DB03610 | |
| 0.019 | 0.088 | 0.062 | Dihydropteroate synthase inhibitor | 0.062 0.011 DB03610 | DB03610 | |
| 0.105 | 0.176 | 0.214 | Sphingosine 1-phosphate receptor 5 antagonist | 0.133 0.093 DBMET01807 0.143 0.074 DBMET01565 0.214 0.007 DB03610 | DB03610 | |
| 0.037 | 0.108 | 0.068 | Glucosylceramidase inhibitor | 0.068 0.023 DB03610 | DB03610 | |
| 0.031 | 0.102 | 0.046 | Baculoviral IAP repeat-containing protein inhibitor | 0.046 0.032 DBMET01565 | DBMET01565 | |
| 0.018 | 0.092 | 0.031 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.031 0.009 DB03610 | DB03610 | |
| 0.042 | 0.115 | 0.189 | Glutamate decarboxylase inhibitor | 0.129 0.018 DBMET01807 0.11 0.025 DBMET01565 0.189 0.008 DB03610 | DB03610 | |
| 0.003 | 0.076 | 0.01 | Thyroid hormone beta agonist | 0.01 0.005 DB03610 | DB03610 | |
| 0.008 | 0.083 | 0.036 | 5 Hydroxytryptamine 1D agonist | 0.036 0.016 DBMET01565 | DBMET01565 | |
| 0.05 | 0.125 | 0.171 | Histamine N-methyltransferase inhibitor | 0.171 0.009 DBMET01565 0.099 0.047 DB03610 | DBMET01565 | |
| 0.015 | 0.091 | 0.124 | Estrogen-related receptor alpha antagonist | 0.124 0.005 DB03610 | DB03610 | |
| 0.071 | 0.148 | 0.115 | Phosphodiesterase 6D inhibitor | 0.115 0.03 DB03610 | DB03610 | |
| 0.03 | 0.107 | 0.066 | Glucagon-like peptide 1 agonist | 0.066 0.044 DBMET01807 | DBMET01807 | |
| 0.046 | 0.123 | 0.119 | Glutamate dehydrogenase inhibitor | 0.076 0.049 DBMET01807 0.109 0.027 DBMET01565 0.119 0.023 DB03610 | DB03610 | |
| 0.019 | 0.096 | 0.053 | Neurokinin 2 antagonist | 0.053 0.022 DB03610 | DB03610 | |
| 0.115 | 0.192 | 0.171 | Focal adhesion kinase 2 inhibitor | 0.171 0.099 DB03610 | DB03610 | |
| 0.015 | 0.094 | 0.071 | Retinoid X alpha receptor agonist | 0.071 0.009 DB03610 | DB03610 | |
| 0.046 | 0.125 | 0.083 | Histone deacetylase SIRT3 inhibitor | 0.083 0.016 DBMET01565 | DBMET01565 | |
| 0.011 | 0.09 | 0.025 | CYP24 inhibitor | 0.025 0.014 DB03610 | DB03610 | |
| 0.048 | 0.127 | 0.274 | Macrophage migration inhibitory factor inhibitor | 0.274 0.005 DB03610 | DB03610 | |
| 0.007 | 0.087 | 0.025 | Prostaglandin EP2 agonist | 0.025 0.015 DB03610 | DB03610 | |
| 0.03 | 0.111 | 0.09 | CC chemokine 2 receptor antagonist | 0.09 0.016 DB03610 | DB03610 | |
| 0.034 | 0.115 | 0.059 | Leukotriene antagonist | 0.059 0.052 DB03610 | DB03610 | |
| 0.093 | 0.175 | 0.225 | Arachidonic acid antagonist | 0.164 0.072 DBMET01565 0.225 0.014 DB03610 | DB03610 | |
| 0.019 | 0.102 | 0.119 | Dopamine D5 agonist | 0.042 0.025 DBMET01807 0.045 0.022 DBMET01565 0.119 0.004 DB03610 | DB03610 | |
| 0.03 | 0.114 | 0.077 | Dopamine beta hydroxylase inhibitor | 0.053 0.025 DBMET01565 0.077 0.005 DB03610 | DB03610 | |
| 0.016 | 0.1 | 0.06 | Urokinase inhibitor | 0.06 0.028 DBMET01807 | DBMET01807 | |
| 0.047 | 0.132 | 0.066 | Metalloproteinase-9 inhibitor | 0.066 0.065 DB03610 | DB03610 | |
| 0.037 | 0.122 | 0.168 | Purinergic P2X1 antagonist | 0.168 0.005 DB03610 | DB03610 | |
| 0.064 | 0.149 | 0.192 | Electrolyte absorption antagonist | 0.098 0.061 DBMET01565 0.192 0.009 DB03610 | DB03610 | |
| 0.087 | 0.173 | 0.205 | Neurotrophic factor | 0.205 0.025 DBMET01565 | DBMET01565 | |
| 0.023 | 0.109 | 0.059 | Sphingosine kinase 1 inhibitor | 0.059 0.01 DB03610 | DB03610 | |
| 0.024 | 0.11 | 0.036 | Aggrecanase 1 inhibitor | 0.036 0.034 DB03610 | DB03610 | |
| 0.013 | 0.099 | 0.042 | Thyroid hormone agonist | 0.042 0.005 DB03610 | DB03610 | |
| 0.048 | 0.135 | 0.087 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.068 0.064 DBMET01807 0.087 0.026 DBMET01565 0.08 0.038 DB03610 | DBMET01565 | |
| 0.045 | 0.132 | 0.122 | Somatostatin 1 agonist | 0.122 0.023 DBMET01807 | DBMET01807 | |
| 0.002 | 0.09 | 0.013 | Progesterone receptor A antagonist | 0.013 0.004 DB03610 | DB03610 | |
| 0.065 | 0.153 | 0.133 | CC chemokine 5 receptor agonist | 0.083 0.055 DBMET01565 0.133 0.005 DB03610 | DB03610 | |
| 0.017 | 0.106 | 0.104 | Histone deacetylase 7 inhibitor | 0.104 0.008 DBMET01565 | DBMET01565 | |
| 0.036 | 0.125 | 0.085 | Transcription factor AP-1 inhibitor | 0.085 0.018 DB03610 | DB03610 | |
| 0.014 | 0.104 | 0.025 | Myristoyl transferase inhibitor | 0.025 0.023 DBMET01565 | DBMET01565 | |
| 0.059 | 0.148 | 0.307 | GABA C receptor agonist | 0.204 0.02 DBMET01807 0.229 0.016 DBMET01565 0.307 0.009 DB03610 | DB03610 | |
| 0.032 | 0.121 | 0.052 | Calcium channel T-type blocker | 0.052 0.051 DB03610 | DB03610 | |
| 0.063 | 0.153 | 0.203 | Cholesterol synthesis inhibitor | 0.203 0.026 DB03610 | DB03610 | |
| 0.041 | 0.131 | 0.091 | Potassium channel (ATP-sensitive) blocker | 0.091 0.02 DBMET01565 0.079 0.029 DB03610 | DBMET01565 | |
| 0.036 | 0.126 | 0.099 | Sphingosine kinase inhibitor | 0.099 0.008 DB03610 | DB03610 | |
| 0.017 | 0.108 | 0.034 | Angiotensin II receptor antagonist | 0.034 0.024 DBMET01565 | DBMET01565 | |
| 0.011 | 0.102 | 0.019 | Potassium channel (Inward rectifier) 11 blocker | 0.019 0.01 DB03610 | DB03610 | |
| 0.073 | 0.164 | 0.156 | Cyclooxygenase 3 inhibitor | 0.123 0.074 DBMET01807 0.156 0.043 DB03610 | DB03610 | |
| 0.011 | 0.104 | 0.026 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.026 0.006 DB03610 | DB03610 | |
| 0.009 | 0.102 | 0.075 | Glutamate (mGluR1a) agonist | 0.075 0.004 DB03610 | DB03610 | |
| 0.008 | 0.102 | 0.029 | Kynurenine 3 monooxygenase inhibitor | 0.027 0.018 DBMET01565 0.029 0.017 DB03610 | DB03610 | |
| 0.009 | 0.103 | 0.018 | CXC chemokine 5 receptor antagonist | 0.018 0.012 DB03610 | DB03610 | |
| 0.07 | 0.164 | 0.401 | Alpha-N-acetylglucosaminidase inhibitor | 0.2 0.034 DBMET01565 0.401 0.009 DB03610 | DB03610 | |
| 0.025 | 0.12 | 0.079 | Vanilloid 3 antagonist | 0.079 0.004 DB03610 | DB03610 | |
| 0.049 | 0.143 | 0.097 | Opioid antagonist | 0.097 0.05 DB03610 | DB03610 | |
| 0.019 | 0.115 | 0.035 | Membrane dipeptidase inhibitor | 0.035 0.034 DBMET01565 | DBMET01565 | |
| 0.105 | 0.201 | 0.239 | Non-steroidal antiinflammatory agent | 0.155 0.108 DBMET01565 0.239 0.047 DB03610 | DB03610 | |
| 0.011 | 0.106 | 0.02 | Neuraminidase (Influenza B) inhibitor | 0.02 0.018 DB03610 | DB03610 | |
| 0.123 | 0.22 | 0.279 | DNA damaging | 0.279 0.066 DBMET01565 0.178 0.137 DB03610 | DBMET01565 | |
| 0.014 | 0.112 | 0.028 | 5 Hydroxytryptamine 6 agonist | 0.028 0.022 DB03610 | DB03610 | |
| 0.064 | 0.161 | 0.251 | AMP-activated protein kinase stimulant | 0.251 0.007 DB03610 | DB03610 | |
| 0.062 | 0.16 | 0.096 | Vanilloid agonist | 0.096 0.038 DB03610 | DB03610 | |
| 0.017 | 0.116 | 0.043 | Angiotensin AT1 receptor antagonist | 0.043 0.027 DBMET01565 | DBMET01565 | |
| 0.01 | 0.109 | 0.021 | Somatostatin 4 antagonist | 0.021 0.02 DBMET01807 | DBMET01807 | |
| 0.022 | 0.122 | 0.07 | Glutamate (mGluR8) agonist | 0.035 0.033 DBMET01807 0.07 0.005 DB03610 | DB03610 | |
| 0.027 | 0.128 | 0.104 | Aconitate hydratase inhibitor | 0.06 0.026 DBMET01565 0.104 0.008 DB03610 | DB03610 | |
| 0.035 | 0.136 | 0.175 | Nav1.8 sodium channel blocker | 0.175 0.01 DB03610 | DB03610 | |
| 0.012 | 0.113 | 0.037 | Sodium/glucose cotransporter inhibitor | 0.037 0.008 DB03610 | DB03610 | |
| 0.022 | 0.125 | 0.083 | Opioid delta receptor antagonist | 0.083 0.035 DB03610 | DB03610 | |
| 0.013 | 0.116 | 0.122 | Sigma receptor antagonist | 0.122 0.014 DBMET01565 | DBMET01565 | |
| 0.046 | 0.15 | 0.152 | Aminopeptidase B inhibitor | 0.11 0.059 DBMET01807 0.142 0.041 DBMET01565 0.152 0.037 DB03610 | DB03610 | |
| 0.062 | 0.166 | 0.1 | Hematopoietic | 0.1 0.036 DBMET01565 | DBMET01565 | |
| 0.011 | 0.116 | 0.04 | Glutamate (mGluR2) antagonist | 0.04 0.012 DB03610 | DB03610 | |
| 0.062 | 0.167 | 0.11 | Protein kinase C gamma inhibitor | 0.103 0.072 DBMET01565 0.11 0.062 DB03610 | DB03610 | |
| 0.015 | 0.12 | 0.052 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.052 0.008 DB03610 | DB03610 | |
| 0.006 | 0.113 | 0.04 | Arginase inhibitor | 0.04 0.022 DB03610 | DB03610 | |
| 0.009 | 0.116 | 0.027 | Progesterone receptor B antagonist | 0.027 0.006 DB03610 | DB03610 | |
| 0.009 | 0.117 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.009 DB03610 | DB03610 | |
| 0.015 | 0.123 | 0.058 | Glutamate (mGluR group II) antagonist | 0.04 0.024 DBMET01807 0.058 0.012 DB03610 | DB03610 | |
| 0.058 | 0.166 | 0.115 | Bile acid receptor antagonist | 0.115 0.025 DB03610 | DB03610 | |
| 0.011 | 0.119 | 0.056 | Free fatty acid receptor 1 antagonist | 0.056 0.007 DB03610 | DB03610 | |
| 0.065 | 0.173 | 0.123 | Microtubule formation inhibitor | 0.109 0.075 DBMET01565 0.123 0.057 DB03610 | DB03610 | |
| 0.003 | 0.112 | 0.023 | G-protein-coupled receptor 120 agonist | 0.023 0.007 DB03610 | DB03610 | |
| 0.04 | 0.149 | 0.066 | Leukotriene C antagonist | 0.066 0.018 DB03610 | DB03610 | |
| 0.031 | 0.141 | 0.076 | Dopamine D1 antagonist | 0.076 0.035 DBMET01565 0.067 0.042 DB03610 | DBMET01565 | |
| 0.136 | 0.246 | 0.27 | Hypoxia-inducible factor 1 alpha inhibitor | 0.258 0.094 DBMET01565 0.27 0.084 DB03610 | DB03610 | |
| 0.034 | 0.144 | 0.111 | Histamine H1 receptor antagonist | 0.111 0.036 DBMET01565 | DBMET01565 | |
| 0.031 | 0.141 | 0.183 | Catalase inhibitor | 0.074 0.051 DBMET01565 0.183 0.019 DB03610 | DB03610 | |
| 0.025 | 0.136 | 0.099 | Nicotinic receptor alpha7 subunit antagonist | 0.099 0.012 DBMET01565 | DBMET01565 | |
| 0.005 | 0.116 | 0.024 | Prostaglandin E2 agonist | 0.024 0.015 DB03610 | DB03610 | |
| 0.044 | 0.155 | 0.101 | Interferon agonist | 0.101 0.028 DBMET01565 0.072 0.066 DB03610 | DBMET01565 | |
| 0.012 | 0.125 | 0.032 | Peptide deformylase inhibitor | 0.032 0.019 DBMET01565 | DBMET01565 | |
| 0.026 | 0.138 | 0.044 | Leukotriene C4 antagonist | 0.044 0.017 DB03610 | DB03610 | |
| 0.155 | 0.268 | 0.256 | Toll-Like receptor 7 agonist | 0.256 0.143 DB03610 | DB03610 | |
| 0.015 | 0.128 | 0.033 | Melanocortin 1 antagonist | 0.033 0.031 DBMET01565 | DBMET01565 | |
| 0.092 | 0.205 | 0.143 | Papain-like protease (SARS coronavirus) inhibitor | 0.132 0.056 DBMET01565 0.143 0.041 DB03610 | DB03610 | |
| 0.026 | 0.141 | 0.059 | Myc inhibitor | 0.059 0.031 DBMET01565 | DBMET01565 | |
| 0.007 | 0.123 | 0.047 | Uridine phosphorylase inhibitor | 0.047 0.009 DB03610 | DB03610 | |
| 0.071 | 0.186 | 0.145 | Cathepsin H inhibitor | 0.145 0.05 DBMET01565 0.128 0.065 DB03610 | DBMET01565 | |
| 0.009 | 0.125 | 0.041 | Carbonic anhydrase IV inhibitor | 0.041 0.032 DBMET01565 | DBMET01565 | |
| 0.019 | 0.134 | 0.048 | Glutamate (mGluR1a) antagonist | 0.048 0.022 DBMET01565 | DBMET01565 | |
| 0.039 | 0.155 | 0.061 | Interferon inducer | 0.061 0.052 DB03610 | DB03610 | |
| 0.144 | 0.261 | 0.323 | Antithrombotic | 0.323 0.075 DBMET01565 0.233 0.141 DB03610 | DBMET01565 | |
| 0.017 | 0.134 | 0.029 | Hedgehog signaling activator | 0.029 0.015 DB03610 | DB03610 | |
| 0.009 | 0.126 | 0.033 | Prostaglandin agonist | 0.033 0.018 DB03610 | DB03610 | |
| 0.05 | 0.168 | 0.157 | Estrogen receptor alpha antagonist | 0.157 0.011 DB03610 | DB03610 | |
| 0.017 | 0.136 | 0.045 | Growth hormone release inhibitor | 0.045 0.026 DBMET01807 | DBMET01807 | |
| 0.085 | 0.204 | 0.169 | DNA repair enzyme inhibitor | 0.169 0.018 DBMET01565 0.124 0.065 DB03610 | DBMET01565 | |
| 0.079 | 0.198 | 0.156 | Transcription factor STAT6 inhibitor | 0.123 0.055 DBMET01807 0.121 0.058 DBMET01565 0.156 0.019 DB03610 | DB03610 | |
| 0.097 | 0.217 | 0.247 | CF transmembrane conductance regulator agonist | 0.247 0.007 DB03610 | DB03610 | |
| 0.151 | 0.272 | 0.446 | Caspase 3 stimulant | 0.446 0.031 DB03610 | DB03610 | |
| 0.066 | 0.187 | 0.18 | Cytokine production inhibitor | 0.18 0.043 DB03610 | DB03610 | |
| 0.056 | 0.177 | 0.232 | Carbonic anhydrase III inhibitor | 0.103 0.058 DBMET01807 0.232 0.011 DB03610 | DB03610 | |
| 0.068 | 0.191 | 0.228 | NADPH oxidase inhibitor | 0.228 0.026 DB03610 | DB03610 | |
| 0.027 | 0.15 | 0.06 | Matrix metalloproteinase inhibitor | 0.06 0.055 DBMET01565 | DBMET01565 | |
| 0.013 | 0.136 | 0.052 | Somatostatin 1 antagonist | 0.052 0.019 DBMET01807 | DBMET01807 | |
| 0.008 | 0.132 | 0.038 | Sodium/glucose cotransporter 2 inhibitor | 0.038 0.009 DB03610 | DB03610 | |
| 0.135 | 0.259 | 0.259 | Calpain 2 inhibitor | 0.259 0.143 DBMET01565 0.244 0.154 DB03610 | DBMET01565 | |
| 0.013 | 0.137 | 0.033 | Glutamate (mGluR1) agonist | 0.033 0.008 DB03610 | DB03610 | |
| 0.039 | 0.163 | 0.077 | Secretase beta inhibitor | 0.077 0.039 DB03610 | DB03610 | |
| 0.025 | 0.151 | 0.076 | Glucose-6-phosphate isomerase inhibitor | 0.076 0.01 DB03610 | DB03610 | |
| 0.036 | 0.161 | 0.078 | Protease 3C (Human rhinovirus) inhibitor | 0.078 0.029 DBMET01565 0.065 0.043 DB03610 | DBMET01565 | |
| 0.015 | 0.14 | 0.077 | Ornithine carbamoyltransferase inhibitor | 0.077 0.023 DBMET01565 0.05 0.039 DB03610 | DBMET01565 | |
| 0.15 | 0.276 | 0.244 | Toll-Like receptor agonist | 0.244 0.154 DB03610 | DB03610 | |
| 0.01 | 0.135 | 0.131 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.131 0.004 DB03610 | DB03610 | |
| 0.007 | 0.133 | 0.049 | Progesterone antagonist | 0.049 0.019 DB03610 | DB03610 | |
| 0.047 | 0.173 | 0.114 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.083 0.058 DBMET01807 0.114 0.028 DB03610 | DB03610 | |
| 0.016 | 0.142 | 0.052 | GABA uptake inhibitor | 0.041 0.025 DBMET01565 0.052 0.014 DB03610 | DB03610 | |
| 0.022 | 0.15 | 0.074 | Opioid mu receptor antagonist | 0.074 0.043 DB03610 | DB03610 | |
| 0.024 | 0.152 | 0.147 | Phosphofructokinase-1 inhibitor | 0.072 0.046 DBMET01565 0.147 0.019 DB03610 | DB03610 | |
| 0.016 | 0.144 | 0.048 | Metalloproteinase-3 inhibitor | 0.048 0.035 DBMET01565 | DBMET01565 | |
| 0.029 | 0.157 | 0.049 | Bombesin 2 receptor antagonist | 0.049 0.035 DB03610 | DB03610 | |
| 0.017 | 0.147 | 0.044 | Glutamate (mGluR3) agonist | 0.034 0.018 DBMET01565 0.044 0.007 DB03610 | DB03610 | |
| 0.021 | 0.151 | 0.051 | Thymidine kinase inhibitor | 0.051 0.018 DB03610 | DB03610 | |
| 0.021 | 0.152 | 0.041 | Phenylethanolamine N methyltransferase inhibitor | 0.041 0.027 DB03610 | DB03610 | |
| 0.023 | 0.155 | 0.046 | Nicotinic receptor alpha4 subunit antagonist | 0.046 0.041 DBMET01565 | DBMET01565 | |
| 0.03 | 0.163 | 0.081 | CD45 antagonist | 0.081 0.012 DB03610 | DB03610 | |
| 0.101 | 0.235 | 0.27 | Succinate dehydrogenase inhibitor | 0.237 0.027 DBMET01565 0.27 0.017 DB03610 | DB03610 | |
| 0.002 | 0.136 | 0.017 | Glutamate (mGluR6) agonist | 0.017 0.005 DB03610 | DB03610 | |
| 0.013 | 0.148 | 0.055 | Geranyltranstransferase inhibitor | 0.055 0.018 DBMET01565 0.048 0.025 DB03610 | DBMET01565 | |
| 0.021 | 0.156 | 0.041 | Glutamate (mGluR group III) agonist | 0.041 0.033 DB03610 | DB03610 | |
| 0.016 | 0.151 | 0.05 | RNA-directed RNA polymerase inhibitor | 0.05 0.013 DB03610 | DB03610 | |
| 0.049 | 0.185 | 0.232 | Ferrochelatase inhibitor | 0.093 0.078 DBMET01807 0.144 0.04 DBMET01565 0.232 0.016 DB03610 | DB03610 | |
| 0.02 | 0.157 | 0.062 | Maillard reaction inhibitor | 0.062 0.033 DB03610 | DB03610 | |
| 0.025 | 0.162 | 0.069 | Glutamate (mGluR group III) antagonist | 0.069 0.01 DB03610 | DB03610 | |
| 0.02 | 0.159 | 0.113 | Argininosuccinate synthase inhibitor | 0.113 0.016 DBMET01565 0.081 0.025 DB03610 | DBMET01565 | |
| 0.007 | 0.147 | 0.024 | CC chemokine 1 receptor antagonist | 0.024 0.016 DB03610 | DB03610 | |
| 0.025 | 0.165 | 0.159 | Vanilloid antagonist | 0.159 0.019 DB03610 | DB03610 | |
| 0.016 | 0.156 | 0.059 | Adenosine deaminase inhibitor | 0.059 0.021 DB03610 | DB03610 | |
| 0.015 | 0.156 | 0.075 | Glutamate (mGluR3) antagonist | 0.036 0.026 DBMET01807 0.075 0.005 DB03610 | DB03610 | |
| 0.045 | 0.188 | 0.159 | Prolactin inhibitor | 0.114 0.043 DBMET01565 0.159 0.019 DB03610 | DB03610 | |
| 0.068 | 0.211 | 0.143 | Antibacterial (Helicobacter pylori) | 0.143 0.053 DBMET01565 | DBMET01565 | |
| 0.089 | 0.232 | 0.229 | Interleukin 6 antagonist | 0.137 0.111 DBMET01807 0.229 0.028 DB03610 | DB03610 | |
| 0.034 | 0.177 | 0.068 | Corticotropin releasing factor 2 receptor antagonist | 0.068 0.031 DB03610 | DB03610 | |
| 0.016 | 0.16 | 0.078 | Estrogen-related receptor beta antagonist | 0.078 0.003 DB03610 | DB03610 | |
| 0.029 | 0.173 | 0.096 | Na+ K+ transporting ATPase inhibitor | 0.096 0.036 DB03610 | DB03610 | |
| 0.068 | 0.212 | 0.568 | Peroxidase inhibitor | 0.136 0.086 DBMET01807 0.149 0.079 DBMET01565 0.568 0.005 DB03610 | DB03610 | |
| 0.026 | 0.172 | 0.234 | Vanilloid 1 antagonist | 0.234 0.008 DB03610 | DB03610 | |
| 0.026 | 0.173 | 0.074 | Acetylcholine M4 receptor antagonist | 0.074 0.053 DBMET01565 | DBMET01565 | |
| 0.068 | 0.215 | 0.272 | Amyloid beta aggregation inhibitor | 0.226 0.066 DBMET01565 0.272 0.051 DB03610 | DB03610 | |
| 0.02 | 0.167 | 0.056 | Elastase inhibitor | 0.056 0.034 DB03610 | DB03610 | |
| 0.019 | 0.167 | 0.053 | Prolyl endopeptidase inhibitor | 0.053 0.032 DBMET01565 | DBMET01565 | |
| 0.003 | 0.153 | 0.015 | Thrombopoietin agonist | 0.015 0.005 DB03610 | DB03610 | |
| 0.055 | 0.205 | 0.141 | D-Ala-D-Ala ligase inhibitor | 0.092 0.041 DBMET01565 0.141 0.007 DB03610 | DB03610 | |
| 0.023 | 0.174 | 0.07 | Glutamate (mGluR4) antagonist | 0.042 0.033 DBMET01565 0.07 0.01 DB03610 | DB03610 | |
| 0.035 | 0.186 | 0.143 | GABA aminotransferase inhibitor | 0.081 0.045 DBMET01807 0.143 0.009 DBMET01565 0.132 0.012 DB03610 | DBMET01565 | |
| 0.016 | 0.166 | 0.066 | Neutrophil collagenase inhibitor | 0.066 0.044 DBMET01565 | DBMET01565 | |
| 0.087 | 0.238 | 0.655 | Aldehyde oxidase inhibitor | 0.286 0.07 DBMET01565 0.655 0.012 DB03610 | DB03610 | |
| 0.06 | 0.211 | 0.228 | Interleukin 12 antagonist | 0.228 0.005 DB03610 | DB03610 | |
| 0.027 | 0.179 | 0.068 | Botulinum neurotoxin type A inhibitor | 0.068 0.027 DB03610 | DB03610 | |
| 0.011 | 0.163 | 0.046 | Histone deacetylase 8 inhibitor | 0.046 0.025 DBMET01565 | DBMET01565 | |
| 0.025 | 0.177 | 0.121 | Lipase inhibitor | 0.121 0.017 DB03610 | DB03610 | |
| 0.04 | 0.193 | 0.211 | Carbonic anhydrase VI inhibitor | 0.075 0.064 DBMET01807 0.211 0.012 DB03610 | DB03610 | |
| 0.009 | 0.165 | 0.037 | Farnesoid X receptor agonist | 0.037 0.028 DB03610 | DB03610 | |
| 0.006 | 0.164 | 0.025 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.025 0.013 DB03610 | DB03610 | |
| 0.023 | 0.182 | 0.156 | NMDA 2B receptor antagonist | 0.156 0.009 DB03610 | DB03610 | |
| 0.02 | 0.18 | 0.103 | Carbamoyl phosphate synthetase inhibitor | 0.059 0.044 DBMET01565 0.103 0.02 DB03610 | DB03610 | |
| 0.004 | 0.166 | 0.201 | Estrogen receptor alpha agonist | 0.201 0.004 DB03610 | DB03610 | |
| 0.052 | 0.214 | 0.119 | Granulocyte macrophage colony stimulating factor agonist | 0.114 0.02 DBMET01565 0.119 0.016 DB03610 | DB03610 | |
| 0.008 | 0.171 | 0.035 | Phosphoglycerate kinase inhibitor | 0.035 0.024 DB03610 | DB03610 | |
| 0.074 | 0.238 | 0.125 | Interleukin 2 antagonist | 0.125 0.038 DB03610 | DB03610 | |
| 0.051 | 0.215 | 0.102 | Proteasome inhibitor | 0.101 0.086 DBMET01565 0.102 0.084 DB03610 | DB03610 | |
| 0.007 | 0.172 | 0.039 | Nicotinic alpha3beta4 receptor agonist | 0.039 0.011 DB03610 | DB03610 | |
| 0.009 | 0.175 | 0.149 | Estradiol 17 beta-dehydrogenase inhibitor | 0.149 0.006 DB03610 | DB03610 | |
| 0.048 | 0.216 | 0.18 | NADH dehydrogenase inhibitor | 0.083 0.068 DBMET01565 0.18 0.012 DB03610 | DB03610 | |
| 0.028 | 0.197 | 0.063 | Prostaglandin F2 alpha antagonist | 0.063 0.042 DB03610 | DB03610 | |
| 0.012 | 0.18 | 0.048 | Phosphodiesterase 2A inhibitor | 0.048 0.038 DB03610 | DB03610 | |
| 0.088 | 0.256 | 0.149 | MAP kinase 3 inhibitor | 0.149 0.069 DB03610 | DB03610 | |
| 0.031 | 0.2 | 0.105 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.105 0.009 DB03610 | DB03610 | |
| 0.031 | 0.2 | 0.085 | Ca(v)3.2 blocker | 0.085 0.012 DB03610 | DB03610 | |
| 0.096 | 0.266 | 0.235 | Calpain inhibitor | 0.235 0.079 DBMET01565 0.186 0.127 DB03610 | DBMET01565 | |
| 0.016 | 0.186 | 0.127 | Raf kinase C inhibitor | 0.127 0.018 DB03610 | DB03610 | |
| 0.063 | 0.233 | 0.25 | Interleukin 4 antagonist | 0.25 0.013 DB03610 | DB03610 | |
| 0.103 | 0.274 | 0.192 | Neurotensin receptor agonist | 0.192 0.039 DBMET01565 0.192 0.039 DB03610 | DB03610 | |
| 0.079 | 0.25 | 0.162 | Insulin secretagoues | 0.162 0.063 DB03610 | DB03610 | |
| 0.063 | 0.234 | 0.129 | CDK3/cyclin E inhibitor | 0.129 0.044 DB03610 | DB03610 | |
| 0.003 | 0.176 | 0.023 | Prostaglandin H2 antagonist | 0.023 0.021 DB03610 | DB03610 | |
| 0.016 | 0.19 | 0.075 | Dihydroorotase inhibitor | 0.075 0.01 DB03610 | DB03610 | |
| 0.063 | 0.237 | 0.17 | Histone deacetylase SIRT1 inhibitor | 0.17 0.046 DBMET01565 | DBMET01565 | |
| 0.143 | 0.317 | 0.304 | Interleukin 2 agonist | 0.304 0.071 DBMET01807 0.215 0.165 DB03610 | DBMET01807 | |
| 0.01 | 0.185 | 0.055 | Phosphodiesterase II inhibitor | 0.055 0.039 DB03610 | DB03610 | |
| 0.043 | 0.218 | 0.27 | UDP-glucose 4-epimerase inhibitor | 0.133 0.036 DBMET01565 0.27 0.012 DB03610 | DB03610 | |
| 0.005 | 0.18 | 0.019 | Telomerase stimulant | 0.019 0.009 DB03610 | DB03610 | |
| 0.085 | 0.26 | 0.231 | Interferon gamma antagonist | 0.133 0.106 DBMET01565 0.231 0.032 DB03610 | DB03610 | |
| 0.074 | 0.249 | 0.152 | Sigma receptor agonist | 0.152 0.084 DBMET01565 | DBMET01565 | |
| 0.096 | 0.272 | 0.207 | Phospholipase C inhibitor | 0.152 0.102 DBMET01807 0.169 0.074 DBMET01565 0.207 0.039 DB03610 | DB03610 | |
| 0.015 | 0.191 | 0.099 | Dihydroorotate dehydrogenase inhibitor | 0.099 0.012 DB03610 | DB03610 | |
| 0.037 | 0.216 | 0.184 | Falcipain 3 inhibitor | 0.184 0.023 DBMET01565 0.09 0.081 DB03610 | DBMET01565 | |
| 0.045 | 0.224 | 0.191 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.118 0.04 DBMET01565 0.191 0.017 DB03610 | DB03610 | |
| 0.15 | 0.33 | 0.187 | MAP kinase kinase 3 inhibitor | 0.187 0.165 DBMET01807 | DBMET01807 | |
| 0.01 | 0.191 | 0.111 | Carbonic anhydrase VB inhibitor | 0.111 0.014 DB03610 | DB03610 | |
| 0.008 | 0.189 | 0.044 | Fumarate hydratase inhibitor | 0.044 0.016 DB03610 | DB03610 | |
| 0.025 | 0.206 | 0.073 | Topoisomerase II beta inhibitor | 0.073 0.015 DB03610 | DB03610 | |
| 0.017 | 0.199 | 0.099 | NMDA receptor glycine site agonist | 0.099 0.017 DB03610 | DB03610 | |
| 0.023 | 0.205 | 0.07 | Protein kinase C beta inhibitor | 0.064 0.06 DBMET01565 0.07 0.048 DB03610 | DB03610 | |
| 0.01 | 0.192 | 0.05 | Purinergic P2Y antagonist | 0.05 0.027 DB03610 | DB03610 | |
| 0.045 | 0.228 | 0.079 | MDM2 inhibitor | 0.079 0.021 DB03610 | DB03610 | |
| 0.007 | 0.19 | 0.025 | Dopamine D1 agonist | 0.025 0.012 DB03610 | DB03610 | |
| 0.019 | 0.202 | 0.037 | Adenosine uptake inhibitor | 0.037 0.018 DBMET01565 | DBMET01565 | |
| 0.011 | 0.195 | 0.03 | Calcium release-activated channel blocker | 0.03 0.029 DB03610 | DB03610 | |
| 0.071 | 0.255 | 0.136 | Thiol protease inhibitor | 0.123 0.111 DBMET01565 0.136 0.085 DB03610 | DB03610 | |
| 0.043 | 0.228 | 0.156 | 5 Hydroxytryptamine 3A agonist | 0.141 0.04 DBMET01565 0.156 0.032 DB03610 | DB03610 | |
| 0.021 | 0.207 | 0.049 | Kainate receptor agonist | 0.049 0.014 DB03610 | DB03610 | |
| 0.012 | 0.198 | 0.068 | NMDA 2C receptor antagonist | 0.068 0.035 DB03610 | DB03610 | |
| 0.163 | 0.353 | 0.386 | MAP kinase kinase 6 inhibitor | 0.386 0.067 DB03610 | DB03610 | |
| 0.022 | 0.213 | 0.111 | Carbonic anhydrase VA inhibitor | 0.111 0.021 DB03610 | DB03610 | |
| 0.005 | 0.198 | 0.038 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.038 0.012 DB03610 | DB03610 | |
| 0.027 | 0.221 | 0.07 | Cathepsin G inhibitor | 0.064 0.062 DBMET01565 0.07 0.054 DB03610 | DB03610 | |
| 0.006 | 0.202 | 0.021 | Isoleucine-tRNA ligase inhibitor | 0.021 0.02 DB03610 | DB03610 | |
| 0.108 | 0.305 | 0.314 | Transcription factor STAT3 inhibitor | 0.179 0.165 DBMET01807 0.19 0.148 DBMET01565 0.314 0.047 DB03610 | DB03610 | |
| 0.013 | 0.211 | 0.115 | Factor XIIIa inhibitor | 0.115 0.005 DBMET01565 | DBMET01565 | |
| 0.031 | 0.23 | 0.092 | Glycine receptor antagonist | 0.092 0.041 DBMET01565 0.083 0.052 DB03610 | DBMET01565 | |
| 0.023 | 0.222 | 0.06 | Heparanase inhibitor | 0.06 0.022 DB03610 | DB03610 | |
| 0.016 | 0.216 | 0.045 | Nicotinic receptor alpha3 subunit antagonist | 0.045 0.029 DBMET01565 | DBMET01565 | |
| 0.056 | 0.256 | 0.081 | T cell inhibitor | 0.081 0.061 DB03610 | DB03610 | |
| 0.007 | 0.208 | 0.038 | Nicotinic acid receptor 2 antagonist | 0.038 0.006 DB03610 | DB03610 | |
| 0.006 | 0.207 | 0.049 | Kainate receptor antagonist | 0.049 0.022 DB03610 | DB03610 | |
| 0.001 | 0.202 | 0.006 | Insulin like growth factor 3 antagonist | 0.006 0.004 DB03610 | DB03610 | |
| 0.018 | 0.222 | 0.118 | Carbonic anhydrase V inhibitor | 0.118 0.022 DB03610 | DB03610 | |
| 0.028 | 0.231 | 0.081 | Acetylcholine nicotinic agonist | 0.081 0.056 DBMET01565 | DBMET01565 | |
| 0.037 | 0.241 | 0.082 | Glutamate (mGluR6) antagonist | 0.082 0.022 DB03610 | DB03610 | |
| 0.002 | 0.209 | 0.018 | Egl nine homolog 3 inhibitor | 0.018 0.005 DB03610 | DB03610 | |
| 0.029 | 0.236 | 0.152 | Butyrylcholinesterase inhibitor | 0.152 0.033 DBMET01565 | DBMET01565 | |
| 0.008 | 0.217 | 0.044 | Histone deacetylase class I inhibitor | 0.044 0.023 DBMET01565 | DBMET01565 | |
| 0.031 | 0.239 | 0.249 | Alcohol dehydrogenase inhibitor | 0.249 0.008 DB03610 | DB03610 | |
| 0.005 | 0.214 | 0.057 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.057 0.006 DB03610 | DB03610 | |
| 0.015 | 0.225 | 0.375 | Alcohol oxidase inhibitor | 0.375 0.004 DB03610 | DB03610 | |
| 0.035 | 0.245 | 0.096 | Mediator release inhibitor | 0.096 0.075 DB03610 | DB03610 | |
| 0.003 | 0.213 | 0.02 | Egl nine homolog 1 inhibitor | 0.02 0.005 DB03610 | DB03610 | |
| 0.022 | 0.232 | 0.078 | Histone deacetylase inhibitor | 0.078 0.033 DBMET01565 | DBMET01565 | |
| 0.091 | 0.302 | 0.236 | Cyclic AMP phosphodiesterase inhibitor | 0.165 0.129 DBMET01565 0.236 0.071 DB03610 | DB03610 | |
| 0.023 | 0.237 | 0.075 | TIE antagonist | 0.075 0.065 DB03610 | DB03610 | |
| 0.033 | 0.246 | 0.068 | Ryanodine receptor antagonist | 0.068 0.02 DB03610 | DB03610 | |
| 0.017 | 0.232 | 0.058 | Diacylglycerol O-acyltransferase inhibitor | 0.058 0.028 DB03610 | DB03610 | |
| 0.043 | 0.259 | 0.123 | MAP kinase kinase 1 inhibitor | 0.123 0.032 DB03610 | DB03610 | |
| 0.014 | 0.231 | 0.14 | Plasminogen activator inhibitor antagonist | 0.14 0.005 DB03610 | DB03610 | |
| 0.044 | 0.261 | 0.107 | MAP kinase kinase 7 inhibitor | 0.082 0.041 DBMET01565 0.107 0.008 DB03610 | DB03610 | |
| 0.064 | 0.281 | 0.152 | Sphingosine 1-phosphate receptor 4 antagonist | 0.124 0.065 DBMET01565 0.152 0.031 DB03610 | DB03610 | |
| 0.011 | 0.23 | 0.051 | Thymidylate synthase inhibitor | 0.051 0.026 DB03610 | DB03610 | |
| 0.019 | 0.239 | 0.059 | Cannabinoid CB1 receptor antagonist | 0.059 0.046 DB03610 | DB03610 | |
| 0.028 | 0.249 | 0.29 | Histone deacetylase stimulant | 0.29 0.004 DB03610 | DB03610 | |
| 0.028 | 0.249 | 0.29 | Histone deacetylase SIRT1 stimulant | 0.29 0.004 DB03610 | DB03610 | |
| 0.011 | 0.239 | 0.038 | Leukocyte elastase inhibitor | 0.038 0.036 DB03610 | DB03610 | |
| 0.019 | 0.248 | 0.219 | Histidine decarboxylase inhibitor | 0.219 0.011 DB03610 | DB03610 | |
| 0.012 | 0.241 | 0.06 | 5 Hydroxytryptamine 4 antagonist | 0.06 0.024 DBMET01565 | DBMET01565 | |
| 0.022 | 0.251 | 0.07 | TIE-2 antagonist | 0.07 0.068 DB03610 | DB03610 | |
| 0.005 | 0.235 | 0.044 | HCV NS5B polymerase inhibitor | 0.044 0.012 DB03610 | DB03610 | |
| 0.014 | 0.244 | 0.04 | Retinoid X alpha receptor antagonist | 0.04 0.015 DB03610 | DB03610 | |
| 0.018 | 0.249 | 0.167 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.167 0.004 DB03610 | DB03610 | |
| 0.074 | 0.308 | 0.241 | 3C-like protease (Human coronavirus) inhibitor | 0.15 0.1 DBMET01565 0.241 0.032 DB03610 | DB03610 | |
| 0.011 | 0.245 | 0.031 | Thymidine phosphorylase inhibitor | 0.031 0.011 DB03610 | DB03610 | |
| 0.008 | 0.243 | 0.047 | Fructose-1,6-bisphosphatase inhibitor | 0.047 0.028 DB03610 | DB03610 | |
| 0.015 | 0.25 | 0.048 | Retinoid X receptor antagonist | 0.048 0.014 DB03610 | DB03610 | |
| 0.033 | 0.269 | 0.117 | Glycine receptor agonist | 0.079 0.04 DBMET01807 0.117 0.013 DB03610 | DB03610 | |
| 0.036 | 0.273 | 0.112 | Protein kinase C zeta inhibitor | 0.112 0.038 DB03610 | DB03610 | |
| 0.007 | 0.244 | 0.246 | Estrogen agonist | 0.246 0.006 DB03610 | DB03610 | |
| 0.061 | 0.298 | 0.142 | Cyclin-dependent kinase 8 inhibitor | 0.142 0.087 DB03610 | DB03610 | |
| 0.046 | 0.284 | 0.196 | Cyclooxygenase inhibitor | 0.196 0.043 DB03610 | DB03610 | |
| 0.02 | 0.258 | 0.213 | Monophenol monooxygenase inhibitor | 0.213 0.03 DB03610 | DB03610 | |
| 0.019 | 0.257 | 0.069 | Purinergic P2X4 antagonist | 0.069 0.01 DB03610 | DB03610 | |
| 0.032 | 0.272 | 0.083 | GABA A receptor agonist | 0.083 0.059 DB03610 | DB03610 | |
| 0.004 | 0.248 | 0.027 | Methionyl aminopeptidase 2 inhibitor | 0.027 0.016 DB03610 | DB03610 | |
| 0.022 | 0.267 | 0.144 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.077 0.053 DBMET01565 0.144 0.021 DB03610 | DB03610 | |
| 0.095 | 0.34 | 0.325 | Gastrin inhibitor | 0.325 0.019 DBMET01565 | DBMET01565 | |
| 0.033 | 0.279 | 0.164 | Keratolytic | 0.164 0.012 DB03610 | DB03610 | |
| 0.035 | 0.284 | 0.118 | Interleukin 1 beta converting enzyme inhibitor | 0.118 0.037 DBMET01565 0.096 0.062 DB03610 | DBMET01565 | |
| 0.015 | 0.265 | 0.047 | AICAR transformylase inhibitor | 0.047 0.026 DB03610 | DB03610 | |
| 0.061 | 0.313 | 0.164 | Immunostimulant | 0.164 0.143 DB03610 | DB03610 | |
| 0.023 | 0.275 | 0.075 | Analgesic, opioid | 0.075 0.055 DB03610 | DB03610 | |
| 0.033 | 0.286 | 0.304 | Cystathionine beta-synthase inhibitor | 0.116 0.061 DBMET01565 0.304 0.009 DB03610 | DB03610 | |
| 0.005 | 0.258 | 0.081 | Urate transporter 1 inhibitor | 0.081 0.008 DB03610 | DB03610 | |
| 0.043 | 0.297 | 0.08 | Interleukin 5 antagonist | 0.08 0.073 DB03610 | DB03610 | |
| 0.004 | 0.258 | 0.039 | CXC chemokine 2 receptor antagonist | 0.039 0.008 DB03610 | DB03610 | |
| 0.036 | 0.29 | 0.118 | GABA receptor agonist | 0.118 0.059 DB03610 | DB03610 | |
| 0.016 | 0.271 | 0.082 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.082 0.019 DB03610 | DB03610 | |
| 0.004 | 0.259 | 0.276 | Thyroid hormone alpha antagonist | 0.276 0.002 DBMET01565 | DBMET01565 | |
| 0.004 | 0.26 | 0.034 | Somatostatin 5 antagonist | 0.034 0.021 DBMET01807 | DBMET01807 | |
| 0.015 | 0.272 | 0.06 | H+/K+-transporting ATPase inhibitor | 0.06 0.026 DBMET01565 | DBMET01565 | |
| 0.108 | 0.366 | 0.286 | Sodium/bile acid cotransporter inhibitor | 0.286 0.092 DBMET01565 0.27 0.108 DB03610 | DBMET01565 | |
| 0.03 | 0.288 | 0.068 | Orexin receptor 1 antagonist | 0.068 0.061 DB03610 | DB03610 | |
| 0.021 | 0.281 | 0.15 | Carbonic anhydrase XIII inhibitor | 0.15 0.022 DB03610 | DB03610 | |
| 0.007 | 0.268 | 0.021 | Retinoid X beta receptor antagonist | 0.021 0.014 DB03610 | DB03610 | |
| 0.046 | 0.308 | 0.227 | DOPA decarboxylase inhibitor | 0.097 0.083 DBMET01565 0.227 0.004 DB03610 | DB03610 | |
| 0.047 | 0.309 | 0.358 | Estrogen antagonist | 0.358 0.005 DB03610 | DB03610 | |
| 0.034 | 0.297 | 0.11 | Chelator | 0.107 0.068 DBMET01565 0.11 0.064 DB03610 | DB03610 | |
| 0.067 | 0.334 | 0.172 | Tumour necrosis factor alpha release inhibitor | 0.172 0.133 DB03610 | DB03610 | |
| 0.063 | 0.33 | 0.147 | Hepatoprotectant | 0.147 0.113 DB03610 | DB03610 | |
| 0.02 | 0.288 | 0.068 | Glucose-6-phosphate translocase inhibitor | 0.068 0.017 DB03610 | DB03610 | |
| 0.013 | 0.281 | 0.112 | Biliverdin reductase inhibitor | 0.112 0.015 DB03610 | DB03610 | |
| 0.003 | 0.271 | 0.029 | Nicotinic acid receptor 1 antagonist | 0.029 0.004 DB03610 | DB03610 | |
| 0.142 | 0.411 | 0.193 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.193 0.186 DBMET01565 | DBMET01565 | |
| 0.011 | 0.283 | 0.055 | Carbonic anhydrase XIV inhibitor | 0.055 0.028 DB03610 | DB03610 | |
| 0.017 | 0.289 | 0.25 | Porphobilinogen synthase inhibitor | 0.076 0.05 DBMET01565 0.25 0.008 DB03610 | DB03610 | |
| 0.013 | 0.287 | 0.075 | Glutamate receptor agonist | 0.075 0.058 DB03610 | DB03610 | |
| 0.013 | 0.287 | 0.115 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.115 0.013 DB03610 | DB03610 | |
| 0.012 | 0.287 | 0.136 | Prostaglandin-E synthase inhibitor | 0.136 0.015 DB03610 | DB03610 | |
| 0.045 | 0.321 | 0.145 | LIM domain kinase 1 inhibitor | 0.145 0.103 DB03610 | DB03610 | |
| 0.005 | 0.282 | 0.034 | Opioid delta receptor agonist | 0.034 0.027 DB03610 | DB03610 | |
| 0.063 | 0.341 | 0.152 | Hemostatic | 0.152 0.065 DB03610 | DB03610 | |
| 0.065 | 0.344 | 0.201 | Growth hormone agonist | 0.201 0.058 DBMET01807 | DBMET01807 | |
| 0.018 | 0.298 | 0.056 | Aldosterone antagonist | 0.056 0.023 DB03610 | DB03610 | |
| 0.005 | 0.292 | 0.048 | AMPA receptor antagonist | 0.048 0.033 DB03610 | DB03610 | |
| 0.006 | 0.295 | 0.057 | Guanylate cyclase inhibitor | 0.057 0.015 DB03610 | DB03610 | |
| 0.082 | 0.374 | 0.325 | Transcription factor STAT inhibitor | 0.185 0.159 DBMET01807 0.181 0.167 DBMET01565 0.325 0.043 DB03610 | DB03610 | |
| 0.022 | 0.314 | 0.054 | CC chemokine receptor 2B antagonist | 0.054 0.025 DB03610 | DB03610 | |
| 0.053 | 0.344 | 0.147 | Neuropeptide Y1 antagonist | 0.147 0.07 DBMET01565 0.124 0.113 DB03610 | DBMET01565 | |
| 0.04 | 0.332 | 0.27 | EphB2 antagonist | 0.27 0.047 DB03610 | DB03610 | |
| 0.003 | 0.299 | 0.028 | NMDA receptor glycine site antagonist | 0.028 0.014 DB03610 | DB03610 | |
| 0.008 | 0.306 | 0.054 | CDK5/p25 inhibitor | 0.054 0.019 DB03610 | DB03610 | |
| 0.007 | 0.305 | 0.054 | Catechol O-methyltransferase inhibitor | 0.041 0.013 DBMET01565 0.054 0.008 DB03610 | DB03610 | |
| 0.105 | 0.409 | 0.354 | Apoptosis antagonist | 0.354 0.054 DB03610 | DB03610 | |
| 0.005 | 0.31 | 0.122 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.122 0.004 DB03610 | DB03610 | |
| 0.007 | 0.313 | 0.075 | Aromatase inhibitor | 0.075 0.03 DB03610 | DB03610 | |
| 0.048 | 0.354 | 0.168 | Farnesoid X receptor antagonist | 0.168 0.036 DB03610 | DB03610 | |
| 0.016 | 0.325 | 0.138 | Protein-tyrosine phosphatase 1B inhibitor | 0.138 0.051 DB03610 | DB03610 | |
| 0.006 | 0.316 | 0.055 | Carbonic anhydrase VII inhibitor | 0.055 0.023 DB03610 | DB03610 | |
| 0.017 | 0.326 | 0.066 | Cyclin D1 inhibitor | 0.066 0.034 DB03610 | DB03610 | |
| 0.003 | 0.313 | 0.194 | Estrogen receptor beta agonist | 0.194 0.005 DB03610 | DB03610 | |
| 0.02 | 0.33 | 0.067 | CXC chemokine 1 receptor antagonist | 0.067 0.015 DB03610 | DB03610 | |
| 0.017 | 0.328 | 0.058 | Lysine-specific demethylase 1A inhibitor | 0.058 0.031 DB03610 | DB03610 | |
| 0.007 | 0.326 | 0.039 | ATP citrate lysase inhibitor | 0.039 0.014 DB03610 | DB03610 | |
| 0.044 | 0.366 | 0.234 | Mannose-6-phosphate isomerase inhibitor | 0.234 0.016 DB03610 | DB03610 | |
| 0.009 | 0.33 | 0.068 | Raf kinase inhibitor | 0.068 0.057 DB03610 | DB03610 | |
| 0.114 | 0.435 | 0.341 | Apoptosis agonist | 0.341 0.144 DB03610 | DB03610 | |
| 0.012 | 0.335 | 0.038 | Protein kinase (CK2) beta inhibitor | 0.038 0.015 DB03610 | DB03610 | |
| 0.071 | 0.4 | 0.247 | DNA synthesis inhibitor | 0.214 0.102 DBMET01565 0.247 0.069 DB03610 | DB03610 | |
| 0.033 | 0.362 | 0.372 | Aryl hydrocarbon receptor agonist | 0.372 0.043 DB03610 | DB03610 | |
| 0.048 | 0.381 | 0.178 | Nitric oxide antagonist | 0.178 0.077 DB03610 | DB03610 | |
| 0.013 | 0.347 | 0.08 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.08 0.072 DB03610 | DB03610 | |
| 0.03 | 0.364 | 0.361 | Estrogen receptor beta antagonist | 0.361 0.004 DB03610 | DB03610 | |
| 0.01 | 0.346 | 0.041 | Somatostatin 5 agonist | 0.041 0.018 DBMET01807 | DBMET01807 | |
| 0.037 | 0.373 | 0.116 | Diuretic | 0.116 0.109 DB03610 | DB03610 | |
| 0.088 | 0.425 | 0.31 | Antibacterial | 0.234 0.192 DBMET01565 0.31 0.128 DB03610 | DB03610 | |
| 0.033 | 0.37 | 0.246 | Amylase inhibitor | 0.109 0.089 DBMET01565 0.246 0.029 DB03610 | DB03610 | |
| 0.048 | 0.39 | 0.185 | Prostaglandin dehydrogenase inhibitor | 0.185 0.168 DB03610 | DB03610 | |
| 0.036 | 0.387 | 0.138 | Angiogenesis stimulant | 0.138 0.13 DB03610 | DB03610 | |
| 0.028 | 0.382 | 0.138 | Thrombolytic | 0.138 0.091 DBMET01807 0.132 0.097 DB03610 | DBMET01807 | |
| 0.065 | 0.42 | 0.217 | Immunosuppressant | 0.217 0.179 DB03610 | DB03610 | |
| 0.034 | 0.394 | 0.212 | MAP kinase kinase 2 inhibitor | 0.212 0.074 DB03610 | DB03610 | |
| 0.017 | 0.378 | 0.078 | Fatty acid synthase inhibitor | 0.078 0.02 DB03610 | DB03610 | |
| 0.006 | 0.368 | 0.045 | Opioid mu receptor agonist | 0.045 0.033 DB03610 | DB03610 | |
| 0.017 | 0.381 | 0.103 | Topoisomerase II alpha inhibitor | 0.103 0.038 DB03610 | DB03610 | |
| 0.028 | 0.393 | 0.132 | Cytidine deaminase inhibitor | 0.132 0.09 DB03610 | DB03610 | |
| 0.117 | 0.484 | 0.434 | Antiinflammatory | 0.434 0.119 DB03610 | DB03610 | |
| 0.005 | 0.372 | 0.055 | Glutamate (mGluR1) antagonist | 0.055 0.044 DBMET01565 | DBMET01565 | |
| 0.026 | 0.393 | 0.202 | Alkaline phosphatase inhibitor | 0.202 0.032 DB03610 | DB03610 | |
| 0.027 | 0.397 | 0.166 | Beta glucuronidase inhibitor | 0.166 0.019 DB03610 | DB03610 | |
| 0.008 | 0.378 | 0.102 | Xanthine dehydrogenase inhibitor | 0.102 0.015 DB03610 | DB03610 | |
| 0.034 | 0.405 | 0.08 | Thioredoxin reductase inhibitor | 0.08 0.061 DB03610 | DB03610 | |
| 0.021 | 0.392 | 0.125 | DNA intercalator | 0.125 0.055 DBMET01565 | DBMET01565 | |
| 0.027 | 0.399 | 0.113 | Caspase 3 inhibitor | 0.112 0.072 DBMET01565 0.113 0.07 DB03610 | DB03610 | |
| 0.053 | 0.432 | 0.163 | Tumour necrosis factor antagonist | 0.14 0.113 DBMET01565 0.163 0.085 DB03610 | DB03610 | |
| 0.068 | 0.458 | 0.183 | Death-associated protein kinase 2 inhibitor | 0.171 0.066 DBMET01807 0.183 0.05 DB03610 | DB03610 | |
| 0.023 | 0.414 | 0.054 | DNA helicase inhibitor | 0.054 0.038 DB03610 | DB03610 | |
| 0.05 | 0.453 | 0.348 | 12-Lipoxygenase inhibitor | 0.179 0.174 DBMET01565 0.348 0.058 DB03610 | DB03610 | |
| 0.016 | 0.42 | 0.08 | Heat shock protein 90 beta antagonist | 0.08 0.021 DB03610 | DB03610 | |
| 0.009 | 0.416 | 0.032 | Glutamate (mGluR4) agonist | 0.032 0.028 DB03610 | DB03610 | |
| 0.006 | 0.417 | 0.068 | Nicotinic acid receptor agonist | 0.068 0.009 DB03610 | DB03610 | |
| 0.052 | 0.481 | 0.209 | Angiogenesis inhibitor | 0.209 0.159 DB03610 | DB03610 | |
| 0.039 | 0.473 | 0.33 | Antioxidant | 0.33 0.052 DB03610 | DB03610 | |
| 0.025 | 0.46 | 0.152 | Xanthine oxidase inhibitor | 0.152 0.034 DB03610 | DB03610 | |
| 0.022 | 0.459 | 0.235 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.235 0.032 DB03610 | DB03610 | |
| 0.005 | 0.441 | 0.104 | Aldose reductase inhibitor | 0.104 0.017 DB03610 | DB03610 | |
| 0.015 | 0.452 | 0.127 | MAP kinase kinase inhibitor | 0.127 0.067 DB03610 | DB03610 | |
| 0.005 | 0.446 | 0.15 | Tyrosine-protein kinase EMT inhibitor | 0.15 0.009 DBMET01565 | DBMET01565 | |
| 0.024 | 0.473 | 0.095 | Thioredoxin inhibitor | 0.095 0.055 DB03610 | DB03610 | |
| 0.009 | 0.458 | 0.07 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.07 0.068 DB03610 | DB03610 | |
| 0.065 | 0.519 | 0.276 | RNA-directed DNA polymerase inhibitor | 0.276 0.038 DB03610 | DB03610 | |
| 0.027 | 0.484 | 0.241 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.241 0.081 DB03610 | DB03610 | |
| 0.007 | 0.476 | 0.051 | Alpha tubulin antagonist | 0.051 0.04 DB03610 | DB03610 | |
| 0.029 | 0.499 | 0.366 | Free radical scavenger | 0.187 0.109 DBMET01565 0.366 0.035 DB03610 | DB03610 | |
| 0.019 | 0.502 | 0.152 | Uric acid excretion stimulant | 0.152 0.022 DB03610 | DB03610 | |
| 0.022 | 0.508 | 0.056 | Adenine nucleotide translocase inhibitor | 0.056 0.038 DB03610 | DB03610 | |
| 0.044 | 0.535 | 0.192 | Histone acetyltransferase inhibitor | 0.155 0.133 DBMET01565 0.192 0.082 DB03610 | DB03610 | |
| 0.015 | 0.507 | 0.168 | Protein-tyrosine phosphatase inhibitor | 0.168 0.064 DB03610 | DB03610 | |
| 0.078 | 0.571 | 0.141 | CC chemokine 6 receptor antagonist | 0.141 0.037 DB03610 | DB03610 | |
| 0.068 | 0.564 | 0.139 | Cyclin-dependent kinase 3 inhibitor | 0.139 0.125 DB03610 | DB03610 | |
| 0.059 | 0.559 | 0.121 | Death-associated protein kinase 1 inhibitor | 0.121 0.11 DB03610 | DB03610 | |
| 0.035 | 0.545 | 0.206 | Hexokinase inhibitor | 0.206 0.032 DB03610 | DB03610 | |
| 0.01 | 0.524 | 0.096 | HIV-1 integrase inhibitor | 0.063 0.061 DBMET01565 0.096 0.027 DB03610 | DB03610 | |
| 0.017 | 0.539 | 0.217 | Pyruvate kinase inhibitor | 0.217 0.073 DB03610 | DB03610 | |
| 0.005 | 0.531 | 0.107 | HIV-1 integrase (3'-Processing) inhibitor | 0.107 0.024 DB03610 | DB03610 | |
| 0.016 | 0.546 | 0.176 | Lipid peroxidase inhibitor | 0.176 0.052 DB03610 | DB03610 | |
| 0.016 | 0.548 | 0.149 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.149 0.121 DB03610 | DB03610 | |
| 0.005 | 0.539 | 0.082 | Protein kinase (CK2) inhibitor | 0.082 0.081 DB03610 | DB03610 | |
| 0.051 | 0.597 | 0.164 | MAP kinase kinase 4 inhibitor | 0.164 0.04 DB03610 | DB03610 | |
| 0.008 | 0.554 | 0.058 | CDC25B inhibitor | 0.058 0.053 DBMET01565 | DBMET01565 | |
| 0.03 | 0.581 | 0.278 | Thyroid hormone antagonist | 0.278 0.106 DBMET01565 | DBMET01565 | |
| 0.031 | 0.583 | 0.257 | Thyroid hormone beta antagonist | 0.257 0.114 DBMET01565 | DBMET01565 | |
| 0.014 | 0.576 | 0.128 | Protein kinase (CK1) gamma 3 inhibitor | 0.128 0.116 DB03610 | DB03610 | |
| 0.03 | 0.598 | 0.316 | 15-Lipoxygenase inhibitor | 0.301 0.131 DBMET01565 0.316 0.121 DB03610 | DB03610 | |
| 0.004 | 0.573 | 0.025 | Protocollagen prolyl hydroxylase inhibitor | 0.025 0.023 DB03610 | DB03610 | |
| 0.01 | 0.582 | 0.115 | Topoisomerase II inhibitor | 0.115 0.071 DB03610 | DB03610 | |
| 0.02 | 0.591 | 0.279 | Alpha-glucosidase inhibitor | 0.279 0.171 DB03610 | DB03610 | |
| 0.019 | 0.613 | 0.133 | DNA methyltransferase I inhibitor | 0.133 0.126 DB03610 | DB03610 | |
| 0.018 | 0.622 | 0.181 | Heat shock protein 90 antagonist | 0.181 0.048 DB03610 | DB03610 | |
| 0.051 | 0.663 | 0.186 | Catenin beta inhibitor | 0.186 0.045 DB03610 | DB03610 | |
| 0.02 | 0.635 | 0.137 | DNA methylase inhibitor | 0.137 0.13 DBMET01565 | DBMET01565 | |
| 0.013 | 0.641 | 0.217 | Heat shock protein 90 alpha antagonist | 0.217 0.04 DB03610 | DB03610 | |
| 0.016 | 0.65 | 0.283 | Streptokinase A inhibitor | 0.283 0.086 DB03610 | DB03610 | |
| 0.017 | 0.651 | 0.207 | Amyloid beta precursor protein antagonist | 0.207 0.053 DB03610 | DB03610 | |
| 0.005 | 0.657 | 0.073 | HIV-1 integrase (Strand Transfer) inhibitor | 0.073 0.034 DB03610 | DB03610 | |
| 0.007 | 0.678 | 0.156 | Cyclooxygenase 2 inhibitor | 0.156 0.049 DB03610 | DB03610 | |
| 0.032 | 0.706 | 0.304 | NOS3 expression enhancer | 0.304 0.017 DB03610 | DB03610 | |
| 0.013 | 0.707 | 0.127 | Dual specificity phosphatase inhibitor | 0.127 0.125 DB03610 | DB03610 | |
| 0.009 | 0.738 | 0.13 | Dual specificity phosphatase 3 inhibitor | 0.13 0.116 DB03610 | DB03610 | |
| 0.005 | 0.828 | 0.129 | Mcl-1 antagonist | 0.129 0.113 DB03610 | DB03610 | |
| 0.006 | 0.83 | 0.464 | Thioredoxin glutathione reductase inhibitor | 0.464 0.036 DBMET01565 | DBMET01565 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |